,assoc,values
0,they buy,community bank trust waco texas lifted position shares abbott laboratories nyse abt 2.8 3rd quarter according company recent 13f filing securities exchange commission .
1,they buy,"institutional investor owned 38,583 shares healthcare product maker stock acquiring additional 1,061 shares quarter ."
2,they buy,"community bank trust waco texas holdings abbott laboratories worth 2,830,000 end recent reporting period ."
3,they buy,several hedge funds institutional investors also recently added reduced stakes abt .
4,they buy,blackrock inc. raised position abbott laboratories 3.7 2nd quarter .
5,they buy,"blackrock inc. owns 116,149,740 shares healthcare product maker stock worth 7,083,972,000 purchasing additional 4,153,157 shares last quarter ."
6,they buy,morgan stanley raised position abbott laboratories 33.1 2nd quarter .
7,they buy,"morgan stanley owns 21,218,276 shares healthcare product maker stock worth 1,294,103,000 purchasing additional 5,274,307 shares last quarter ."
8,they buy,janus henderson group plc raised position abbott laboratories 12.0 2nd quarter .
9,they buy,"janus henderson group plc owns 13,708,172 shares healthcare product maker stock worth 836,067,000 purchasing additional 1,468,430 shares last quarter ."
10,they buy,dimensional fund advisors lp raised position abbott laboratories 0.7 2nd quarter .
11,they buy,"dimensional fund advisors lp owns 9,477,591 shares healthcare product maker stock worth 578,069,000 purchasing additional 67,093 shares last quarter ."
12,they buy,finally swiss national bank raised position abbott laboratories 3.3 2nd quarter .
13,they buy,"swiss national bank owns 5,998,788 shares healthcare product maker stock worth 365,866,000 purchasing additional 190,600 shares last quarter ."
14,they buy,72.16 stock currently owned institutional investors .
15,they sell,"related news insider daniel gesua sive salvadori sold 5,000 shares business stock transaction dated friday september 28th ."
16,they sell,"stock sold average price 73.39 total value 366,950.00 ."
17,they buy,"following completion sale insider directly owns 93,321 shares company stock valued approximately 6,848,828.19 ."
18,they buy,sale disclosed filing securities exchange commission accessible link .
19,they sell,"also insider michael j. pederson sold 1,050 shares business stock transaction dated tuesday july 24th ."
20,they sell,"shares sold average price 63.43 total value 66,601.50 ."
21,they buy,"following completion sale insider directly owns 79,467 shares company stock valued 5,040,591.81 ."
22,they buy,disclosure sale found .
23,they sell,"insiders sold total 155,321 shares company stock valued 10,492,583 last ninety days ."
24,they buy,0.74 stock currently owned corporate insiders .
25,they buy,abt stock opened 69.33 friday .
26,they buy,abbott laboratories 1-year low 53.61 1-year high 74.15 .
27,they buy,company debt-to-equity ratio 0.64 current ratio 1.58 quick ratio 1.16. stock market capitalization 128.70 billion pe ratio 27.73 price-to-earnings-growth ratio 2.05 beta 1.49 .
28,they buy,abbott laboratories nyse abt last posted quarterly earnings data wednesday july 18th .
29,they buy,healthcare product maker reported 0.73 earnings per share quarter topping thomson reuters consensus estimate 0.71 0.02 .
30,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
31,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
32,they buy,period last year company posted 0.62 eps .
33,they buy,business quarterly revenue 17.0 year-over-year basis .
34,they sell,analysts expect abbott laboratories post 2.88 earnings per share current year .
35,they buy,company also recently announced quarterly dividend paid thursday november 15th .
36,they buy,investors record monday october 15th given 0.28 dividend .
37,they buy,represents 1.12 dividend annualized basis yield 1.62 .
38,they buy,ex-dividend date dividend friday october 12th .
39,they buy,abbott laboratories payout ratio 44.80 .
40,they buy,abbott laboratories profile want see hedge funds holding abt visit holdingschannel.com get latest 13f filings insider trades abbott laboratories nyse abt .
41,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
42,they buy,name required equities analysts forecast abbott laboratories nyse abt post earnings 0.74 per share current fiscal quarter according zacks investment research .
43,they buy,seven analysts issued estimates abbott laboratories earnings estimates ranging 0.73 0.75 .
44,they buy,abbott laboratories posted earnings 0.66 per share quarter last year indicates positive year year growth rate 12.1 .
45,they buy,business expected report next earnings report market opens wednesday october 17th .
46,they buy,according zacks analysts expect abbott laboratories report full year earnings 2.88 per share current financial year eps estimates ranging 2.85 2.90 .
47,they buy,next year analysts expect business post earnings 3.24 per share eps estimates ranging 3.15 3.30 .
48,they sell,zacks earnings per share averages average based survey sell-side research firms cover abbott laboratories .
49,they buy,abbott laboratories nyse abt last posted quarterly earnings results wednesday july 18th .
50,they buy,healthcare product maker reported 0.73 eps quarter beating consensus estimate 0.71 0.02 .
51,they buy,firm revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
52,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
53,they buy,company revenue quarter 17.0 year-over-year basis .
54,they buy,quarter prior year firm posted 0.62 eps .
55,they buy,shares abt stock traded 1.23 trading hours friday hitting 69.33 .
56,they buy,"company trading volume 10,345,615 shares compared average volume 6,017,730. abbott laboratories 12 month low 53.61 12 month high 74.15 ."
57,they buy,firm market cap 128.70 billion p/e ratio 27.73 p/e/g ratio 2.05 beta 1.49. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
58,they buy,firm also recently declared quarterly dividend paid thursday november 15th .
59,they buy,investors record monday october 15th given dividend 0.28 per share .
60,they buy,ex-dividend date dividend friday october 12th .
61,they buy,represents 1.12 dividend annualized basis yield 1.62 .
62,they buy,abbott laboratories dividend payout ratio dpr presently 44.80 .
63,they sell,"related news insider daniel gesua sive salvadori sold 5,000 shares stock transaction occurred friday september 28th ."
64,they sell,"stock sold average price 73.39 total transaction 366,950.00 ."
65,they buy,"following sale insider directly owns 93,321 shares company valued approximately 6,848,828.19 ."
66,they buy,transaction disclosed filing sec accessed hyperlink .
67,they sell,also insider sharon j. bracken sold 615 shares stock transaction occurred monday july 30th .
68,they sell,"stock sold average price 65.16 total value 40,073.40 ."
69,they buy,"following sale insider owns 40,761 shares company valued 2,655,986.76 ."
70,they buy,disclosure sale found .
71,they sell,"last 90 days insiders sold 155,321 shares company stock worth 10,492,583 ."
72,they buy,0.74 stock owned corporate insiders .
73,they buy,number hedge funds institutional investors recently added reduced stakes abt .
74,they buy,"atlantic trust llc bought new stake abbott laboratories 2nd quarter worth approximately 104,000 ."
75,they buy,"rainier group investment advisory llc bought new stake abbott laboratories 1st quarter worth approximately 114,000 ."
76,they buy,"fny investment advisers llc bought new stake abbott laboratories 2nd quarter worth approximately 118,000 ."
77,they buy,"fort l.p. bought new stake abbott laboratories 2nd quarter worth approximately 119,000 ."
78,they buy,finally security national bank dak grew position abbott laboratories 72.0 2nd quarter .
79,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 acquiring additional 878 shares last quarter ."
80,they buy,institutional investors hedge funds 72.16 company stock .
81,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
82,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
83,they buy,"see also insider trading need knowviewcount articlehistoryid=25271840 postdate=2018-10-13 type=c quarternary=1 id=485966keyword abbott laboratories nyse abt abt medical,00282410 ratings consensusratings:4,18 nyse abt get free copy zacks research report abbott laboratories abt information research offerings zacks investment research visit zacks.com brokerages expect abbott laboratories nyse abt report sales 7.67 billion current fiscal quarter according zacks ."
84,they buy,seven analysts provided estimates abbott laboratories earnings highest sales estimate coming 7.71 billion lowest estimate coming 7.63 billion .
85,they buy,abbott laboratories reported sales 6.83 billion quarter last year would suggest positive year-over-year growth rate 12.3 .
86,they buy,business scheduled issue next quarterly earnings report market opens wednesday october 17th .
87,they buy,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c average analysts expect abbott laboratories report full year sales 30.78 billion current fiscal year estimates ranging 30.67 billion 30.91 billion .
88,they buy,next fiscal year analysts anticipate firm post sales 32.52 billion estimates ranging 31.99 billion 32.87 billion .
89,they buy,zacks sales averages mean average based survey analysts cover abbott laboratories .
90,they buy,abbott laboratories nyse abt last posted earnings results wednesday july 18th .
91,they buy,healthcare product maker reported 0.73 earnings per share quarter beating zacks consensus estimate 0.71 0.02 .
92,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
93,they buy,company revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
94,they buy,quarter last year company earned 0.62 earnings per share .
95,they buy,company revenue quarter 17.0 year-over-year basis .
96,they buy,number research analysts recently weighed company .
97,they buy,royal bank canada restated buy rating issued 70.00 target price shares abbott laboratories report thursday july 19th .
98,they buy,cowen raised target price abbott laboratories 72.00 86.00 gave company average rating report friday october 5th .
99,they buy,jpmorgan chase co. raised target price abbott laboratories 77.00 81.00 gave company overweight rating report monday .
100,they buy,sanford c. bernstein began coverage abbott laboratories report wednesday june 27th .
101,they buy,issued outperform rating 73.00 target price stock .
102,they buy,finally raymond james lifted price target abbott laboratories 72.00 77.00 gave stock outperform rating report monday september 24th .
103,they sell,one investment analyst rated stock sell rating four assigned hold rating fifteen issued buy rating company .
104,they buy,abbott laboratories presently consensus rating buy average target price 73.17 .
105,they buy,shares abt stock traded 0.19 trading hours monday reaching 68.73 .
106,they buy,"company trading volume 1,611,819 shares compared average volume 5,964,736. abbott laboratories 12 month low 53.61 12 month high 74.15 ."
107,they buy,company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. firm market capitalization 128.70 billion pe ratio 27.72 p/e/g ratio 2.05 beta 1.49 .
108,they buy,firm also recently declared quarterly dividend paid thursday november 15th .
109,they buy,investors record monday october 15th issued dividend 0.28 per share .
110,they buy,ex-dividend date dividend friday october 12th .
111,they buy,represents 1.12 dividend annualized basis yield 1.63 .
112,they buy,abbott laboratories dividend payout ratio dpr currently 44.80 .
113,they sell,"abbott laboratories news insider daniel gesua sive salvadori sold 5,000 shares firm stock transaction friday september 28th ."
114,they sell,"stock sold average price 73.39 total value 366,950.00 ."
115,they buy,"following completion sale insider directly owns 93,321 shares company stock valued 6,848,828.19 ."
116,they buy,transaction disclosed document filed securities exchange commission accessible link .
117,they sell,"also insider andrew h. lane sold 9,097 shares firm stock transaction wednesday august 29th ."
118,they sell,"stock sold average price 67.11 total value 610,499.67 ."
119,they buy,"following completion sale insider directly owns 35,576 shares company stock valued 2,387,505.36 ."
120,they buy,disclosure sale found .
121,they sell,"insiders sold 155,321 shares company stock worth 10,492,583 last quarter ."
122,they buy,0.74 stock currently owned corporate insiders .
123,they buy,get free copy zacks research report abbott laboratories abt information research offerings zacks investment research visit zacks.com google_ad_client ca-pub-0703139142419429 google_ad_slot 1418630638 google_ad_width 336 google_ad_height 280 abbott laboratories nyse abt price objective lifted equities research analysts cowen 72.00 86.00 report issued friday october 5th fly reports .
124,they buy,firm currently average rating healthcare product maker stock .
125,they buy,cowen price target would suggest potential upside 24.04 stock previous close .
126,they buy,several research firms also recently commented abt .
127,they buy,raymond james upped price target shares abbott laboratories 72.00 77.00 gave company outperform rating research report monday september 24th .
128,they buy,wells fargo co upped price target shares abbott laboratories 77.00 80.00 gave company outperform rating research report monday september 24th .
129,they buy,zacks investment research downgraded shares abbott laboratories buy rating hold rating research report wednesday september 19th .
130,they buy,stifel nicolaus upped price target shares abbott laboratories 71.00 72.00 gave company buy rating research report thursday july 19th .
131,they buy,finally royal bank canada reiterated buy rating issued 70.00 price target shares abbott laboratories research report thursday july 19th .
132,they sell,one analyst rated stock sell rating four issued hold rating fifteen given buy rating company .
133,they buy,stock consensus rating buy average price target 73.72 .
134,they buy,shares abbott laboratories stock traded 1.23 trading hours friday hitting 69.33 .
135,they buy,"company trading volume 10,345,615 shares compared average volume 6,017,730. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
136,they buy,company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64. stock market cap 128.70 billion price-to-earnings ratio 27.73 peg ratio 2.05 beta 1.49 .
137,they buy,abbott laboratories nyse abt last issued earnings results wednesday july 18th .
138,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating consensus estimate 0.71 0.02 .
139,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
140,they buy,business revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
141,they buy,quarter prior year business posted 0.62 eps .
142,they buy,company revenue quarter 17.0 year-over-year basis .
143,they sell,average analysts forecast abbott laboratories post 2.88 earnings per share current fiscal year .
144,they sell,"news evp brian j. blaser sold 15,100 shares stock transaction dated tuesday july 24th ."
145,they sell,"shares sold average price 63.96 total value 965,796.00 ."
146,they buy,"following completion transaction executive vice president owns 151,718 shares company valued approximately 9,703,883.28 ."
147,they buy,sale disclosed legal filing securities exchange commission accessible sec website .
148,they sell,also insider sharon j. bracken sold 615 shares stock transaction dated monday july 30th .
149,they sell,"shares sold average price 65.16 total transaction 40,073.40 ."
150,they buy,"following completion transaction insider owns 40,761 shares company stock valued approximately 2,655,986.76 ."
151,they buy,disclosure sale found .
152,they sell,"insiders sold total 155,321 shares company stock valued 10,492,583 last quarter ."
153,they buy,insiders 0.74 company stock .
154,they buy,number hedge funds institutional investors recently modified holdings abt .
155,they buy,"gsa capital partners llp purchased new stake shares abbott laboratories first quarter valued approximately 1,107,000 ."
156,they buy,"financial advisory group bought new stake shares abbott laboratories first quarter worth 210,000 ."
157,they buy,first pacific advisors llc increased stake shares abbott laboratories 170.1 first quarter .
158,they buy,"first pacific advisors llc owns 20,800 shares healthcare product maker stock worth 1,246,000 buying additional 13,100 shares last quarter ."
159,they buy,asset management one co. ltd. increased stake shares abbott laboratories 1.1 first quarter .
160,they buy,"asset management one co. ltd. owns 2,773,008 shares healthcare product maker stock worth 166,159,000 buying additional 31,039 shares last quarter ."
161,they buy,finally koch industries inc. increased stake shares abbott laboratories 100.6 first quarter .
162,they buy,"koch industries inc. owns 8,200 shares healthcare product maker stock worth 491,000 buying additional 4,113 shares last quarter ."
163,they buy,72.16 stock currently owned hedge funds institutional investors .
164,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
165,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
166,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 boost price target cowen incratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
167,they buy,magna international mga research coverage started barclays wall street brokerages forecast abbott laboratories nyse abt announce sales 7.67 billion current fiscal quarter zacks reports .
168,they buy,seven analysts provided estimates abbott laboratories earnings .
169,they buy,highest sales estimate 7.71 billion lowest 7.63 billion .
170,they buy,abbott laboratories reported sales 6.83 billion quarter last year would suggest positive year-over-year growth rate 12.3 .
171,they buy,business expected issue next quarterly earnings report market opens wednesday october 17th .
172,they buy,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c average analysts expect abbott laboratories report full year sales 30.78 billion current fiscal year estimates ranging 30.67 billion 30.91 billion .
173,they buy,next year analysts expect company report sales 32.52 billion estimates ranging 31.99 billion 32.87 billion .
174,they sell,zacks sales calculations mean average based survey sell-side analysts follow abbott laboratories .
175,they buy,abbott laboratories nyse abt last announced quarterly earnings data wednesday july 18th .
176,they buy,healthcare product maker reported 0.73 earnings per share quarter topping consensus estimate 0.71 0.02 .
177,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
178,they buy,business revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
179,they buy,period prior year company earned 0.62 eps .
180,they buy,abbott laboratories revenue quarter 17.0 year-over-year basis .
181,they buy,several analysts recently weighed company .
182,they buy,royal bank canada upped price objective abbott laboratories 77.00 gave stock outperform rating research report thursday .
183,they sell,zacks investment research downgraded abbott laboratories hold rating sell rating research report monday .
184,they buy,jpmorgan chase co. upped price objective abbott laboratories 77.00 81.00 gave stock overweight rating research report monday .
185,they buy,cowen upped price objective abbott laboratories 72.00 86.00 gave stock average rating research report friday october 5th .
186,they buy,finally raymond james upped price objective abbott laboratories 72.00 77.00 gave stock outperform rating research report monday september 24th .
187,they sell,one investment analyst rated stock sell rating four assigned hold rating fifteen issued buy rating stock .
188,they buy,abbott laboratories consensus rating buy consensus price target 73.17 .
189,they buy,shares abt stock traded 0.19 monday hitting 68.73 .
190,they buy,"1,611,819 shares company stock exchanged compared average volume 5,964,736. company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. abbott laboratories 12 month low 53.61 12 month high 74.15 ."
191,they buy,company market cap 128.70 billion p/e ratio 27.72 p/e/g ratio 2.05 beta 1.49 .
192,they buy,company also recently announced quarterly dividend paid thursday november 15th .
193,they buy,shareholders record monday october 15th given 0.28 dividend .
194,they buy,ex-dividend date dividend friday october 12th .
195,they buy,represents 1.12 annualized dividend yield 1.63 .
196,they buy,abbott laboratories dividend payout ratio presently 44.80 .
197,they sell,"news insider daniel gesua sive salvadori sold 5,000 shares stock transaction dated friday september 28th ."
198,they sell,"stock sold average price 73.39 total value 366,950.00 ."
199,they buy,"following completion sale insider owns 93,321 shares company stock valued 6,848,828.19 ."
200,they buy,sale disclosed legal filing sec available link .
201,they sell,"also insider michael j. pederson sold 1,050 shares stock transaction dated tuesday july 24th ."
202,they sell,"shares sold average price 63.43 total value 66,601.50 ."
203,they buy,"following completion sale insider directly owns 79,467 shares company stock valued approximately 5,040,591.81 ."
204,they buy,disclosure sale found .
205,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last quarter ."
206,they buy,corporate insiders 0.74 company stock .
207,they sell,"get free copy zacks research report abbott laboratories abt information research offerings zacks investment research visit zacks.com google_ad_client ca-pub-0703139142419429 google_ad_slot 1418630638 google_ad_width 336 google_ad_height 280 abbott laboratories nyse abt insider daniel gesua sive salvadori sold 5,000 shares firm stock transaction dated friday september 28th ."
208,they sell,"shares sold average price 73.39 total value 366,950.00 ."
209,they buy,"following completion transaction insider owns 93,321 shares company valued approximately 6,848,828.19 ."
210,they buy,transaction disclosed document filed securities exchange commission accessed hyperlink .
211,they buy,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c abt stock opened 68.38 friday .
212,they buy,company market cap 128.70 billion p/e ratio 27.35 price-to-earnings-growth ratio 2.05 beta 1.49. abbott laboratories 1-year low 53.61 1-year high 74.15 .
213,they buy,company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
214,they buy,abbott laboratories nyse abt last released quarterly earnings results wednesday july 18th .
215,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating thomson reuters consensus estimate 0.71 0.02 .
216,they buy,business revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
217,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
218,they buy,firm quarterly revenue 17.0 year-over-year basis .
219,they buy,period previous year company posted 0.62 eps .
220,they buy,equities analysts forecast abbott laboratories post 2.88 eps current year .
221,they buy,business also recently announced quarterly dividend paid thursday november 15th .
222,they buy,stockholders record monday october 15th given dividend 0.28 per share .
223,they buy,ex-dividend date friday october 12th .
224,they buy,represents 1.12 dividend annualized basis dividend yield 1.64 .
225,they buy,abbott laboratories payout ratio 44.80 .
226,they buy,several research firms recently issued reports abt .
227,they buy,royal bank canada reiterated buy rating issued 70.00 price target shares abbott laboratories report thursday july 19th .
228,they buy,stifel nicolaus raised price target abbott laboratories 71.00 72.00 gave company buy rating report thursday july 19th .
229,they buy,jpmorgan chase co. raised target price abbott laboratories 77.00 81.00 gave stock overweight rating report monday .
230,they buy,zacks investment research cut abbott laboratories buy rating hold rating report monday august 6th .
231,they buy,finally sanford c. bernstein initiated coverage abbott laboratories report wednesday june 27th .
232,they buy,set outperform rating 73.00 target price stock .
233,they sell,one equities research analyst rated stock sell rating four given hold rating fifteen assigned buy rating stock .
234,they buy,stock consensus rating buy consensus target price 73.17 .
235,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
236,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
237,they buy,united services automobile association raised position shares abbott laboratories nyse abt 3.6 second quarter according company recent filing securities exchange commission .
238,they buy,"institutional investor owned 1,392,206 shares healthcare product maker stock purchasing additional 48,042 shares period ."
239,they buy,"united services automobile association owned 0.08 abbott laboratories worth 84,911,000 recent filing securities exchange commission ."
240,they buy,hedge funds institutional investors also recently modified holdings company .
241,they buy,city holding co. grew stake abbott laboratories 1.6 2nd quarter .
242,they buy,"city holding co. owns 50,654 shares healthcare product maker stock valued 3,089,000 purchasing additional 782 shares last quarter ."
243,they buy,moody national bank trust division lifted holdings shares abbott laboratories 7.3 2nd quarter .
244,they buy,"moody national bank trust division owns 11,757 shares healthcare product maker stock valued 717,000 buying additional 795 shares period ."
245,they buy,sullivan bruyette speros blaney llc lifted holdings shares abbott laboratories 4.2 2nd quarter .
246,they buy,"sullivan bruyette speros blaney llc owns 19,760 shares healthcare product maker stock valued 1,205,000 buying additional 796 shares period ."
247,they buy,holdings securities inc. lifted holdings shares abbott laboratories 7.4 2nd quarter .
248,they buy,"holdings securities inc. owns 11,538 shares healthcare product maker stock valued 704,000 buying additional 796 shares period ."
249,they buy,finally north star asset management inc. lifted holdings shares abbott laboratories 0.3 2nd quarter .
250,they buy,"north star asset management inc. owns 275,593 shares healthcare product maker stock valued 16,808,000 buying additional 828 shares period ."
251,they buy,72.16 stock owned institutional investors hedge funds .
252,they buy,abt stock opened 69.33 friday .
253,they buy,company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. company market capitalization 128.70 billion pe ratio 27.69 p/e/g ratio 2.05 beta 1.49. abbott laboratories 1 year low 53.61 1 year high 74.15 .
254,they buy,firm also recently disclosed quarterly dividend paid thursday november 15th .
255,they buy,investors record monday october 15th given 0.28 dividend .
256,they buy,ex-dividend date dividend friday october 12th .
257,they buy,represents 1.12 annualized dividend yield 1.62 .
258,they buy,abbott laboratories payout ratio 44.80 .
259,they buy,several equities analysts recently issued reports abt shares .
260,they buy,zacks investment research raised abbott laboratories hold rating buy rating set 77.00 price objective company report tuesday september 18th .
261,they buy,wells fargo co upped price target abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
262,they buy,raymond james upped price target abbott laboratories 72.00 77.00 gave stock outperform rating report monday september 24th .
263,they buy,stifel nicolaus upped price target abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
264,they buy,finally sanford c. bernstein initiated coverage abbott laboratories report wednesday june 27th .
265,they buy,issued outperform rating 73.00 price target company .
266,they sell,one equities research analyst rated stock sell rating four assigned hold rating fifteen issued buy rating company stock .
267,they buy,stock currently consensus rating buy consensus target price 73.72 .
268,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
269,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
270,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed2 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
271,they buy,teck resources teck trading 5.2 wealthtrust fairport llc boosted position shares abbott laboratories nyse abt 1.8 2nd quarter according company recent disclosure securities exchange commission .
272,they buy,"firm owned 117,216 shares healthcare product maker stock buying additional 2,109 shares period ."
273,they buy,"wealthtrust fairport llc holdings abbott laboratories worth 7,149,000 recent sec filing ."
274,they buy,number institutional investors hedge funds also recently added reduced stakes business .
275,they buy,venturi wealth management llc raised holdings abbott laboratories 18.7 1st quarter .
276,they buy,"venturi wealth management llc owns 12,695 shares healthcare product maker stock worth 761,000 purchasing additional 2,000 shares last quarter ."
277,they buy,sector gamma raised holdings abbott laboratories 2.4 1st quarter .
278,they buy,"sector gamma owns 1,105,642 shares healthcare product maker stock worth 66,250,000 purchasing additional 25,800 shares last quarter ."
279,they buy,tredje ap fonden raised holdings abbott laboratories 1.6 1st quarter .
280,they buy,"tredje ap fonden owns 445,656 shares healthcare product maker stock worth 26,704,000 purchasing additional 7,204 shares last quarter ."
281,they buy,cambridge investment research advisors inc. raised holdings abbott laboratories 1.7 1st quarter .
282,they buy,"cambridge investment research advisors inc. owns 202,155 shares healthcare product maker stock worth 12,113,000 purchasing additional 3,327 shares last quarter ."
283,they buy,"finally silvant capital management llc bought new position abbott laboratories 1st quarter worth 160,000 ."
284,they buy,72.16 stock currently owned institutional investors .
285,they buy,shares abt stock opened 69.33 friday .
286,they buy,abbott laboratories one year low 53.61 one year high 74.15 .
287,they buy,stock market cap 128.70 billion p/e ratio 27.69 peg ratio 2.05 beta 1.49. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
288,they buy,company also recently disclosed quarterly dividend paid thursday november 15th .
289,they buy,investors record monday october 15th given dividend 0.28 per share .
290,they buy,represents 1.12 annualized dividend yield 1.62 .
291,they buy,ex-dividend date friday october 12th .
292,they buy,abbott laboratories dividend payout ratio dpr 44.80 .
293,they buy,several brokerages recently issued reports abt .
294,they buy,cowen increased price target shares abbott laboratories 72.00 86.00 gave stock average rating research note friday october 5th .
295,they buy,royal bank canada reiterated buy rating issued 70.00 price target shares abbott laboratories research note thursday july 19th .
296,they buy,zacks investment research upgraded shares abbott laboratories hold rating buy rating set 70.00 price target company research note thursday july 19th .
297,they buy,stifel nicolaus increased price target shares abbott laboratories 71.00 72.00 gave stock buy rating research note thursday july 19th .
298,they buy,finally raymond james increased price target shares abbott laboratories 72.00 77.00 gave stock outperform rating research note monday september 24th .
299,they sell,one equities research analyst rated stock sell rating four issued hold rating fifteen assigned buy rating stock .
300,they buy,abbott laboratories consensus rating buy consensus price target 73.72 .
301,they sell,related news insider sharon j. bracken sold 615 shares stock transaction dated monday july 30th .
302,they sell,"shares sold average price 65.16 total transaction 40,073.40 ."
303,they buy,"following sale insider directly owns 40,761 shares company stock valued approximately 2,655,986.76 ."
304,they buy,sale disclosed legal filing securities exchange commission accessible sec website .
305,they sell,"also insider michael j. pederson sold 1,050 shares firm stock transaction dated tuesday july 24th ."
306,they sell,"shares sold average price 63.43 total transaction 66,601.50 ."
307,they buy,"following sale insider directly owns 79,467 shares company valued approximately 5,040,591.81 ."
308,they buy,disclosure sale found .
309,they sell,"insiders sold total 155,321 shares company stock worth 10,492,583 last three months ."
310,they buy,0.74 stock currently owned insiders .
311,they buy,"abbott laboratories company profile keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
312,they buy,iost iost trading 12.5 lower week truvestments capital llc bought new stake abbott laboratories nyse abt 2nd quarter according company recent filing securities exchange commission .
313,they buy,"fund bought 11,240 shares healthcare product maker stock valued approximately 686,000 ."
314,they sell,number institutional investors hedge funds also recently bought sold shares business .
315,they buy,"atlantic trust llc purchased new stake shares abbott laboratories second quarter worth 104,000 ."
316,they buy,"rainier group investment advisory llc purchased new stake shares abbott laboratories first quarter worth 114,000 ."
317,they buy,"fny investment advisers llc purchased new stake shares abbott laboratories second quarter worth 118,000 ."
318,they buy,"fort l.p. purchased new stake shares abbott laboratories second quarter worth 119,000 ."
319,they buy,finally security national bank dak grew stake shares abbott laboratories 72.0 second quarter .
320,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 acquiring additional 878 shares last quarter ."
321,they buy,institutional investors 72.16 company stock .
322,they buy,shares abt stock opened 69.33 friday .
323,they buy,company debt-to-equity ratio 0.64 current ratio 1.58 quick ratio 1.16. company market cap 128.70 billion pe ratio 27.69 price-to-earnings-growth ratio 2.05 beta 1.49. abbott laboratories 1-year low 53.61 1-year high 74.15 .
324,they buy,firm also recently announced quarterly dividend paid thursday november 15th .
325,they buy,stockholders record monday october 15th paid dividend 0.28 per share .
326,they buy,represents 1.12 annualized dividend dividend yield 1.62 .
327,they buy,ex-dividend date friday october 12th .
328,they buy,abbott laboratories payout ratio 44.80 .
329,they buy,number equities research analysts recently weighed abt shares .
330,they buy,cowen boosted price target abbott laboratories 72.00 86.00 gave stock average rating research note friday october 5th .
331,they buy,royal bank canada reiterated buy rating issued 70.00 target price shares abbott laboratories research report thursday july 19th .
332,they buy,zacks investment research upgraded abbott laboratories hold rating buy rating set 70.00 target price stock research report thursday july 19th .
333,they buy,stifel nicolaus upped target price abbott laboratories 71.00 72.00 gave company buy rating research report thursday july 19th .
334,they buy,finally raymond james upped target price abbott laboratories 72.00 77.00 gave company outperform rating research report monday september 24th .
335,they sell,one equities research analyst rated stock sell rating four assigned hold rating fifteen issued buy rating company .
336,they buy,company presently consensus rating buy consensus price target 73.72 .
337,they sell,"related news insider andrew h. lane sold 9,097 shares business stock transaction occurred wednesday august 29th ."
338,they sell,"stock sold average price 67.11 total transaction 610,499.67 ."
339,they buy,"following completion sale insider directly owns 35,576 shares company valued 2,387,505.36 ."
340,they buy,sale disclosed document filed securities exchange commission accessed sec website .
341,they sell,"also insider michael j. pederson sold 1,050 shares company stock transaction tuesday july 24th ."
342,they sell,"shares sold average price 63.43 total value 66,601.50 ."
343,they buy,"following completion sale insider owns 79,467 shares company stock valued 5,040,591.81 ."
344,they buy,disclosure sale found .
345,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last quarter ."
346,they buy,0.74 stock owned company insiders .
347,they buy,"abbott laboratories profile keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
348,they buy,name required sp asset management purchased new position shares abbott laboratories nyse abt second quarter according recent 13f filing securities exchange commission .
349,they buy,"fund purchased 107,034 shares healthcare product maker stock valued approximately 6,671,000 ."
350,they buy,abbott laboratories comprises 1.8 sp asset management portfolio making stock 12th biggest position .
351,they sell,number institutional investors hedge funds also bought sold shares abt .
352,they buy,blackrock inc. raised stake abbott laboratories 3.7 second quarter .
353,they buy,"blackrock inc. owns 116,149,740 shares healthcare product maker stock worth 7,083,972,000 purchasing additional 4,153,157 shares period ."
354,they buy,morgan stanley raised stake abbott laboratories 33.1 second quarter .
355,they buy,"morgan stanley owns 21,218,276 shares healthcare product maker stock worth 1,294,103,000 purchasing additional 5,274,307 shares period ."
356,they buy,janus henderson group plc raised stake abbott laboratories 12.0 second quarter .
357,they buy,"janus henderson group plc owns 13,708,172 shares healthcare product maker stock worth 836,067,000 purchasing additional 1,468,430 shares period ."
358,they buy,dimensional fund advisors lp raised stake abbott laboratories 0.7 second quarter .
359,they buy,"dimensional fund advisors lp owns 9,477,591 shares healthcare product maker stock worth 578,069,000 purchasing additional 67,093 shares period ."
360,they buy,finally franklin resources inc. raised stake abbott laboratories 5.2 first quarter .
361,they buy,"franklin resources inc. owns 9,042,686 shares healthcare product maker stock worth 541,838,000 purchasing additional 446,071 shares period ."
362,they buy,hedge funds institutional investors 72.16 company stock .
363,they buy,shares abt stock opened 69.33 friday .
364,they buy,company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. company market capitalization 128.70 billion p/e ratio 27.69 price-to-earnings-growth ratio 2.05 beta 1.49. abbott laboratories fifty-two week low 53.61 fifty-two week high 74.15 .
365,they buy,firm also recently disclosed quarterly dividend paid thursday november 15th .
366,they buy,investors record monday october 15th issued 0.28 dividend .
367,they buy,represents 1.12 dividend annualized basis dividend yield 1.62 .
368,they buy,ex-dividend date friday october 12th .
369,they buy,abbott laboratories dividend payout ratio dpr currently 44.80 .
370,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
371,they buy,"hamayou akbar hussain sells 40,255 shares hiscox ltd hsx stock abbott laboratories nyse abt price target increased wells fargo co 77.00 80.00 report published monday september 24th ."
372,they buy,brokerage currently outperform rating healthcare product maker stock .
373,they buy,number research firms also recently commented abt .
374,they buy,stifel nicolaus upped price objective abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
375,they buy,zacks investment research downgraded abbott laboratories buy rating hold rating report monday august 6th .
376,they buy,royal bank canada restated buy rating set 70.00 price objective shares abbott laboratories report thursday july 19th .
377,they buy,finally sanford c. bernstein started coverage abbott laboratories report wednesday june 27th .
378,they buy,set outperform rating 73.00 price objective company .
379,they sell,one equities research analyst rated stock sell rating four issued hold rating fifteen assigned buy rating company stock .
380,they buy,abbott laboratories presently consensus rating buy consensus price target 73.72 .
381,they buy,abt stock opened 69.33 monday .
382,they buy,firm market cap 128.70 billion pe ratio 27.69 peg ratio 2.05 beta 1.49. company debt-to-equity ratio 0.64 current ratio 1.58 quick ratio 1.16. abbott laboratories 52 week low 53.61 52 week high 74.15 .
383,they buy,business also recently declared quarterly dividend paid thursday november 15th .
384,they buy,investors record monday october 15th issued 0.28 dividend .
385,they buy,ex-dividend date friday october 12th .
386,they buy,represents 1.12 annualized dividend yield 1.62 .
387,they buy,abbott laboratories dividend payout ratio currently 44.80 .
388,they sell,number large investors recently bought sold shares abt .
389,they buy,abbrea capital llc lifted position shares abbott laboratories 4.1 first quarter .
390,they buy,"abbrea capital llc owns 27,565 shares healthcare product maker stock worth 1,652,000 purchasing additional 1,089 shares last quarter ."
391,they buy,lido advisors llc lifted position shares abbott laboratories 109.6 first quarter .
392,they buy,"lido advisors llc owns 11,987 shares healthcare product maker stock worth 718,000 purchasing additional 6,269 shares last quarter ."
393,they buy,matthew goff investment advisor llc lifted position shares abbott laboratories 2.0 first quarter .
394,they buy,"matthew goff investment advisor llc owns 104,315 shares healthcare product maker stock worth 6,251,000 purchasing additional 2,033 shares last quarter ."
395,they buy,toronto dominion bank lifted position shares abbott laboratories 42.4 first quarter .
396,they buy,"toronto dominion bank owns 1,101,208 shares healthcare product maker stock worth 65,970,000 purchasing additional 328,063 shares last quarter ."
397,they buy,finally peapack gladstone financial corp lifted position shares abbott laboratories 2.0 first quarter .
398,they buy,"peapack gladstone financial corp owns 102,664 shares healthcare product maker stock worth 6,152,000 purchasing additional 1,975 shares last quarter ."
399,they buy,72.16 stock owned institutional investors .
400,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
401,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
402,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 boost price target wells fargo coratings:4,18 nyse abtrefreshed2 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
403,they buy,name required windsor group ltd increased stake abbott laboratories nyse abt 44.0 third quarter according recent form 13f filing sec .
404,they buy,"firm owned 6,828 shares healthcare product maker stock purchasing additional 2,087 shares period ."
405,they buy,"windsor group ltd holdings abbott laboratories worth 501,000 recent filing sec ."
406,they buy,several hedge funds institutional investors also recently modified holdings stock .
407,they buy,franklin street advisors inc. nc boosted stake abbott laboratories 21.4 third quarter .
408,they buy,"franklin street advisors inc. nc owns 4,622 shares healthcare product maker stock valued 339,000 buying additional 815 shares last quarter ."
409,they buy,"peachtree investment advisors inc. acquired new stake abbott laboratories third quarter valued 240,000 ."
410,they buy,burns j w co. inc. ny boosted stake abbott laboratories 3.2 third quarter .
411,they buy,"burns j w co. inc. ny owns 25,006 shares healthcare product maker stock valued 1,834,000 buying additional 785 shares last quarter ."
412,they buy,smithbridge asset management inc. de boosted stake abbott laboratories 3.9 third quarter .
413,they buy,"smithbridge asset management inc. de owns 42,061 shares healthcare product maker stock valued 3,086,000 buying additional 1,590 shares last quarter ."
414,they buy,finally wealth architects llc boosted stake abbott laboratories 25.9 third quarter .
415,they buy,"wealth architects llc owns 9,825 shares healthcare product maker stock valued 721,000 buying additional 2,022 shares last quarter ."
416,they buy,institutional investors 72.16 company stock .
417,they sell,"news evp brian j. blaser sold 15,100 shares firm stock transaction dated tuesday july 24th ."
418,they sell,"stock sold average price 63.96 total transaction 965,796.00 ."
419,they buy,"following completion transaction executive vice president directly owns 151,718 shares company valued 9,703,883.28 ."
420,they buy,sale disclosed filing securities exchange commission available hyperlink .
421,they sell,also insider sharon j. bracken sold 615 shares firm stock transaction dated monday july 30th .
422,they sell,"stock sold average price 65.16 total value 40,073.40 ."
423,they buy,"following transaction insider owns 40,761 shares company stock valued 2,655,986.76 ."
424,they buy,disclosure sale found .
425,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last 90 days ."
426,they buy,0.74 stock owned corporate insiders .
427,they buy,shares abt stock traded 0.95 mid-day trading friday reaching 69.33 .
428,they buy,"1,003,882 shares stock traded hands compared average volume 5,995,051. abbott laboratories 1-year low 53.61 1-year high 74.15 ."
429,they buy,firm market capitalization 128.70 billion price-to-earnings ratio 27.69 peg ratio 2.05 beta 1.49. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
430,they buy,abbott laboratories nyse abt last announced quarterly earnings results wednesday july 18th .
431,they buy,healthcare product maker reported 0.73 eps quarter beating zacks consensus estimate 0.71 0.02 .
432,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
433,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
434,they sell,period last year firm posted 0.62 earnings per share .
435,they buy,business revenue quarter 17.0 year-over-year basis .
436,they sell,average sell-side analysts predict abbott laboratories post 2.88 earnings per share current fiscal year .
437,they buy,business also recently disclosed quarterly dividend paid thursday november 15th .
438,they buy,stockholders record monday october 15th given dividend 0.28 per share .
439,they buy,ex-dividend date friday october 12th .
440,they buy,represents 1.12 dividend annualized basis dividend yield 1.62 .
441,they buy,abbott laboratories dividend payout ratio dpr 44.80 .
442,they buy,several analysts recently weighed company .
443,they buy,royal bank canada raised price objective abbott laboratories 77.00 gave company outperform rating research note thursday .
444,they buy,zacks investment research lowered abbott laboratories buy rating hold rating research note tuesday july 31st .
445,they buy,wells fargo co raised price objective abbott laboratories 77.00 80.00 gave company outperform rating research note monday september 24th .
446,they buy,raymond james raised price objective abbott laboratories 72.00 77.00 gave company outperform rating research note monday september 24th .
447,they buy,finally jpmorgan chase co. lifted price target abbott laboratories 77.00 81.00 gave company overweight rating research note monday .
448,they sell,one equities research analyst rated stock sell rating four issued hold rating fifteen assigned buy rating company stock .
449,they buy,abbott laboratories presently average rating buy consensus target price 73.72 .
450,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
451,they sell,gilead sciences inc. gild shares sold wendell david associates inc .
452,they buy,menlo advisors llc lessened holdings abbott laboratories nyse abt 1.9 3rd quarter according recent disclosure securities exchange commission sec .
453,they buy,"institutional investor owned 41,758 shares healthcare product maker stock selling 805 shares period ."
454,they buy,abbott laboratories accounts approximately 2.1 menlo advisors llc portfolio making stock 23rd largest holding .
455,they buy,"menlo advisors llc holdings abbott laboratories worth 3,063,000 recent sec filing ."
456,they buy,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c several hedge funds institutional investors also made changes positions business .
457,they buy,morgan stanley lifted stake shares abbott laboratories 33.1 second quarter .
458,they buy,"morgan stanley owns 21,218,276 shares healthcare product maker stock valued 1,294,103,000 buying additional 5,274,307 shares period ."
459,they buy,"charles schwab investment advisory inc. purchased new position shares abbott laboratories second quarter valued approximately 275,697,000 ."
460,they buy,american century companies inc. lifted stake shares abbott laboratories 417.9 second quarter .
461,they buy,"american century companies inc. owns 5,586,119 shares healthcare product maker stock valued 340,697,000 buying additional 4,507,553 shares period ."
462,they buy,blackrock inc. lifted stake shares abbott laboratories 3.7 second quarter .
463,they buy,"blackrock inc. owns 116,149,740 shares healthcare product maker stock valued 7,083,972,000 buying additional 4,153,157 shares period ."
464,they buy,"finally swedbank purchased new position shares abbott laboratories second quarter valued approximately 101,535,000 ."
465,they buy,72.16 stock currently owned institutional investors .
466,they buy,abt stock traded 1.39 wednesday hitting 69.90 .
467,they buy,"514,029 shares company exchanged compared average volume 5,941,136. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
468,they buy,company debt-to-equity ratio 0.64 quick ratio 1.16 current ratio 1.58. firm market capitalization 128.70 billion price-to-earnings ratio 28.39 price-to-earnings-growth ratio 2.05 beta 1.49 .
469,they buy,abbott laboratories nyse abt last issued quarterly earnings results wednesday july 18th .
470,they buy,healthcare product maker reported 0.73 eps quarter topping consensus estimate 0.71 0.02 .
471,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
472,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
473,they buy,quarter prior year business posted 0.62 earnings per share .
474,they buy,abbott laboratories revenue quarter 17.0 compared quarter last year .
475,they buy,group equities analysts forecast abbott laboratories post 2.88 eps current fiscal year .
476,they buy,business also recently declared quarterly dividend paid thursday november 15th .
477,they buy,investors record monday october 15th given dividend 0.28 per share .
478,they buy,represents 1.12 annualized dividend yield 1.60 .
479,they buy,ex-dividend date friday october 12th .
480,they buy,abbott laboratories dividend payout ratio dpr 44.80 .
481,they buy,abbott laboratories investors sentiment increased 0.86 2018 q2 .
482,they buy,0.03 0.83 2018q1 .
483,they sell,positive 41 investors sold abbott laboratories shares 583 reduced holdings .
484,they buy,117 funds opened positions 420 raised stakes .
485,they buy,1.23 billion shares 0.63 1.22 billion shares 2018q1 reported .
486,they buy,veritable l p 0.17 invested abbott laboratories nyse abt .
487,they buy,state treasurer state michigan stated 0.25 portfolio abbott laboratories nyse abt .
488,they buy,hsbc public limited liability holds 0.19 1.72 million shares .
489,they buy,cornerstone cap invested 3.25 abbott laboratories nyse abt .
490,they buy,fjarde ap reported 0.45 stake .
491,they buy,"bbva compass bancorporation 0.97 invested abbott laboratories nyse abt 251,582 shares ."
492,they buy,"gradient invests limited liability corporation holds 0.5 152,860 shares ."
493,they buy,georgia-based first city capital mngmt incorporated invested 0.55 abbott laboratories nyse abt .
494,they buy,"glenview national bank trust trust dept accumulated 66,571 shares ."
495,they buy,"iowa bankshares accumulated 29,356 shares ."
496,they buy,nippon life ins communications stated 0.35 abbott laboratories nyse abt .
497,they buy,"calamos wealth ltd reported 9,178 shares ."
498,they buy,"805,312 owned bank trust corp. moreover markston ltd llc 0.54 invested abbott laboratories nyse abt ."
499,they buy,main street research ltd liability com invested 0.05 portfolio abbott laboratories nyse abt .
500,they buy,since april 23 2018 0 buys 10 insider sales 14.54 million activity .
501,they sell,"capek john sold 4.22 million worth stock 64,900 shares ."
502,they sell,"another trade 849 shares valued 50,397 sold contreras jaime ."
503,they sell,"friday may 4 insider bracken sharon j sold 125,909 ."
504,they sell,"pederson michael j sold 66,601 worth stock ."
505,they sell,"thursday may 17 salvadori daniel gesua sive sold 183,592 worth abbott laboratories nyse abt 3,000 shares ."
506,they sell,"58,200 shares valued 4.00m sold blaser brian j thursday september 20 ."
507,they buy,analysts expect abbott laboratories nyse abt report 0.74 eps october 17.they anticipate 0.08 eps change 12.12 last quarter 0.66 eps .
508,they buy,abt profit would 1.30 billion giving 23.10 p/e 0.74 eps correct .
509,they buy,0.73 eps previously abbott laboratories analysts see 1.37 eps growth .
510,they buy,stock decreased 0.78 0.54 last trading session reaching 68.38 .
511,they buy,11.93m shares traded 119.72 average .
512,they buy,abbott laboratories nyse abt risen 28.17 since october 12 2017 uptrending .
513,they buy,outperformed 12.55 p500 .
514,they sell,among 8 analysts covering abbott labs nyse abt 7 buy rating 0 sell 1 hold .
515,they sell,therefore 88 positive .
516,they buy,abbott labs 81 highest 65 lowest target .
517,they buy,74.50 average target 8.95 currents 68.38 stock price .
518,they buy,abbott labs 8 analyst reports since april 18 2018 according sratingsintel .
519,they buy,raymond james maintained abbott laboratories nyse abt rating monday september 24. raymond james outperform rating 77 target .
520,they buy,firm buy rating jefferies given wednesday april 18. rating maintained citigroup neutral tuesday april 24. wells fargo maintained abbott laboratories nyse abt monday september 24 outperform rating .
521,they buy,jp morgan maintained stock overweight rating monday october 8 report .
522,they buy,stock abbott laboratories nyse abt earned buy rating stifel nicolaus thursday july 19. stock abbott laboratories nyse abt overweight rating given thursday october 11 morgan stanley .
523,they buy,abbott laboratories manufactures sells health care products worldwide .
524,they buy,company market cap 119.96 billion .
525,they buy,companyâ established pharmaceutical products segment offers branded generic pharmaceuticals treat pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism mã©niã¨re disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin cardiovascular metabolic products influenza vaccines well regulate physiological rhythm colon .
526,they buy,131 p/e ratio .
527,they buy,company diagnostic products segment provides immunoassay clinical chemistry systems assays used screen and/or diagnosis cancer cardiac drugs abuse fertility infectious diseases therapeutic drug monitoring hematology systems reagents diagnostic systems cartridges instruments automate extraction purification preparation dna rna patient samples detects measures infectious agents genomic tests informatics automation solutions suite informatics tools professional services .
528,they buy,news abbott laboratories nyse abt recently published seekingalpha.com released abbott mitraclip success provides upside stock september 24 2018. seekingalpha.com article titled medical device makers red published october 08 2018 yet another important article .
529,they buy,receive news ratings via email enter email address receive concise daily summary latest news analysts ratings free daily email newsletter .
530,they buy,contravisory investment management inc. cut position abbott laboratories nyse abt 3.5 third quarter according company recent 13f filing securities exchange commission .
531,they buy,"firm owned 72,437 shares healthcare product maker stock selling 2,654 shares quarter ."
532,they buy,abbott laboratories makes 1.9 contravisory investment management inc. investment portfolio making stock 19th biggest holding .
533,they buy,"contravisory investment management inc. holdings abbott laboratories worth 5,314,000 end recent quarter ."
534,they buy,hedge funds institutional investors also recently made changes positions company .
535,they buy,"atlantic trust llc purchased new stake abbott laboratories 2nd quarter valued approximately 104,000 ."
536,they buy,"rainier group investment advisory llc purchased new stake abbott laboratories 1st quarter valued approximately 114,000 ."
537,they buy,"fny investment advisers llc purchased new stake abbott laboratories 2nd quarter valued approximately 118,000 ."
538,they buy,"fort l.p. purchased new stake abbott laboratories 2nd quarter valued approximately 119,000 ."
539,they buy,finally security national bank dak raised stake abbott laboratories 72.0 2nd quarter .
540,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock valued 128,000 acquiring additional 878 shares last quarter ."
541,they buy,72.16 stock owned hedge funds institutional investors .
542,they buy,abt subject several analyst reports .
543,they buy,cowen upped price objective abbott laboratories 72.00 86.00 gave company average rating research note friday october 5th .
544,they buy,royal bank canada reaffirmed buy rating set 70.00 price objective shares abbott laboratories research note thursday july 19th .
545,they buy,zacks investment research raised abbott laboratories hold rating buy rating set 70.00 price objective company research note thursday july 19th .
546,they buy,stifel nicolaus upped price objective abbott laboratories 71.00 72.00 gave company buy rating research note thursday july 19th .
547,they buy,finally raymond james upped price objective abbott laboratories 72.00 77.00 gave company outperform rating research note monday september 24th .
548,they sell,one analyst rated stock sell rating four issued hold rating fifteen assigned buy rating company stock .
549,they buy,company presently average rating buy average target price 73.17 .
550,they buy,abbott laboratories nyse abt last issued earnings results wednesday july 18th .
551,they buy,healthcare product maker reported 0.73 earnings per share eps quarter topping analysts consensus estimates 0.71 0.02 .
552,they buy,business revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
553,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
554,they buy,company revenue quarter 17.0 year-over-year basis .
555,they buy,period prior year business posted 0.62 eps .
556,they sell,average equities research analysts expect abbott laboratories post 2.88 earnings per share current year .
557,they buy,firm also recently announced quarterly dividend paid thursday november 15th .
558,they buy,stockholders record monday october 15th paid dividend 0.28 per share .
559,they buy,represents 1.12 dividend annualized basis dividend yield 1.64 .
560,they buy,ex-dividend date dividend friday october 12th .
561,they buy,abbott laboratories dividend payout ratio dpr 44.80 .
562,they sell,"related news insider michael j. pederson sold 1,050 shares company stock transaction occurred tuesday july 24th ."
563,they sell,"stock sold average price 63.43 total value 66,601.50 ."
564,they buy,"following sale insider owns 79,467 shares company valued approximately 5,040,591.81 ."
565,they buy,transaction disclosed legal filing sec accessible hyperlink .
566,they sell,also insider sharon j. bracken sold 615 shares company stock transaction occurred monday july 30th .
567,they sell,"stock sold average price 65.16 total value 40,073.40 ."
568,they buy,"following completion sale insider owns 40,761 shares company valued approximately 2,655,986.76 ."
569,they buy,disclosure sale found .
570,they sell,"last three months insiders sold 155,321 shares company stock valued 10,492,583 ."
571,they buy,company insiders 0.74 company stock .
572,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
573,they buy,abbott laboratories abt shares bought gofen glossberg llc il wells fargo co wfc expected post earnings 1.17 per share name required abbott laboratories nyse abt stock enjoyed overall uptrend 19.82 beginning 2018. closing share price quoted october 11 2018 68.38 .
574,they sell,drop might tempting investor sell point fact would prove short-sighted mistake sell-side analysts think almost 25.77 gain yet come shareholders .
575,they buy,analysts seemed set 86 highest price target way greater gains .
576,they buy,average 12-month price target expect stock 73.71 .
577,they buy,mean price target represents 7.79 upside previous closing price .
578,they buy,median price target presented 73 next 12-months suggests 6.76 upside current levels .
579,they buy,analysts lowest price target stock 57 would mean gain value .
580,they buy,fresh roundup today notes abt stock added around 25.61 value past 12 months suggesting investors expressed joy time period .
581,they buy,turn street general positives still outweigh negatives see abbott laboratories abt buy 1.8 analyst consensus rating .
582,they buy,current time stock 14 buy 4 hold ratings .
583,they buy,stock registered 52-week high 74.15 october 01 52-week low 53.61 november 01. currently shares trading 5.76 ytd moving average 62.62 .
584,they buy,moving abbott laboratories abt last reported june 2018 earnings .
585,they buy,brief highlights performed well quarter earnings 18 year-over-year 0.73 .
586,they sell,company surprised analysts 3 expecting 0.71 per share .
587,they buy,overall quarterly revenues jumped 17 reach 7.77 billion reported 6.64 billion period year ago .
588,they buy,see investors really expect september 2018 financial results consensus analyst estimates calling current quarter earnings per share 0.74 0.66 quarter year ago .
589,they buy,however earnings-per-share expected see growth 12.02 next year .
590,they buy,company believes achieve long-term annual earnings growth rate 11.84 .
591,they buy,end income statement seen revenue 29.58 billion trailing 12 months .
592,they buy,help decide whether worth wait money abbott laboratories nyse abt currently trading 52.32x company trailing-12-month earnings per share represents premium compared sector 32.75x comes industry 32.83x .
593,they buy,popular method valuing stock study historic price-to-earnings p/e ratio using reported earnings past 12 months .
594,they buy,eps number stock recent four quarters earnings stood 1.31 .
595,they buy,p/e ratio popular simple effective tautologically everyone uses .
596,they buy,14-day absolute atr average true range thursday october 11 2018 shows price average moves 1.19 .
597,they buy,average daily volatility 2.35 past week .
598,they buy,low volatility good stock means calm confident investors .
599,they buy,check recent abbott laboratories abt volume see changed 11.92 million shares versus average daily volume 5.31 million shares .
600,they buy,look daily chart abt observe stock held 16.91 gains 6-month period maintains 27.55 distance recent low .
601,they buy,past 5-day performance share stays negative three-week moving average .
602,they buy,comparing 50-day sma abbott laboratories shares price 1.11 .
603,they buy,also closed 9.44 higher 200-day sma .
604,they buy,often seen last line defense long term trends find support else considered broken and/or bear market .
605,they buy,daily chart stock clearly reveals slide prices closed thursday 1-month performance 2.11 .
606,they buy,posted trina covell oct 12th 2018 comments wall street access asset management llc acquired new position shares abbott laboratories nyse abt 3rd quarter according recent disclosure sec .
607,they buy,"institutional investor acquired 4,468 shares healthcare product maker stock valued approximately 327,000 ."
608,they buy,several institutional investors hedge funds also recently modified holdings abt .
609,they buy,"atlantic trust llc purchased new stake abbott laboratories 2nd quarter valued 104,000 ."
610,they buy,"rainier group investment advisory llc purchased new stake abbott laboratories 1st quarter valued 114,000 ."
611,they buy,"fny investment advisers llc purchased new stake abbott laboratories 2nd quarter valued 118,000 ."
612,they buy,"fort l.p. purchased new stake abbott laboratories 2nd quarter valued 119,000 ."
613,they buy,finally security national bank dak raised holdings abbott laboratories 72.0 2nd quarter .
614,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock valued 128,000 buying additional 878 shares period ."
615,they buy,72.16 stock currently owned institutional investors hedge funds .
616,they sell,"news svp sharon j. bracken sold 1,732 shares stock transaction friday september 28th ."
617,they sell,"stock sold average price 73.35 total transaction 127,042.20 ."
618,they buy,"following transaction senior vice president owns 39,229 shares company stock valued approximately 2,877,447.15 ."
619,they buy,transaction disclosed filing securities exchange commission available link .
620,they sell,"also svp jaime contreras sold 64,268 shares stock transaction wednesday august 29th ."
621,they sell,"stock sold average price 66.84 total value 4,295,673.12 ."
622,they buy,"following transaction senior vice president directly owns 125,471 shares company valued approximately 8,386,481.64 ."
623,they buy,disclosure sale found .
624,they sell,"last quarter insiders sold 155,321 shares company stock worth 10,492,583 ."
625,they buy,insiders 0.74 company stock .
626,they buy,abbott laboratories nyse abt last released earnings results wednesday july 18th .
627,they buy,healthcare product maker reported 0.73 earnings per share quarter topping analysts consensus estimates 0.71 0.02 .
628,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
629,they buy,business revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
630,they sell,quarter last year firm posted 0.62 earnings per share .
631,they buy,business revenue 17.0 compared quarter last year .
632,they sell,sell-side analysts predict abbott laboratories post 2.88 earnings per share current fiscal year .
633,they buy,firm also recently announced quarterly dividend paid thursday november 15th .
634,they buy,shareholders record monday october 15th paid 0.28 dividend .
635,they buy,ex-dividend date friday october 12th .
636,they buy,represents 1.12 dividend annualized basis yield 1.64 .
637,they buy,abbott laboratories payout ratio 44.80 .
638,they buy,several research firms recently weighed abt .
639,they sell,zacks investment research lowered abbott laboratories hold rating sell rating report monday .
640,they buy,cowen increased price target abbott laboratories 72.00 86.00 gave company average rating report friday october 5th .
641,they buy,jpmorgan chase co. increased price target abbott laboratories 77.00 81.00 gave company overweight rating report monday .
642,they buy,raymond james increased price target abbott laboratories 72.00 77.00 gave company outperform rating report monday september 24th .
643,they buy,finally wells fargo co increased price target abbott laboratories 77.00 80.00 gave company outperform rating report monday september 24th .
644,they sell,one analyst rated stock sell rating four assigned hold rating fifteen given buy rating company stock .
645,they buy,stock currently average rating buy average price target 73.17 .
646,they buy,abbott laboratories profile abbott laboratories discovers develops manufactures sells health care products worldwide .
647,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
648,they buy,want see hedge funds holding abt visit holdingschannel.com get latest 13f filings insider trades abbott laboratories nyse abt .
649,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
650,they buy,mccormick co nv mkc shares bought wendell david associates inc .
651,they buy,technicals front abbott laboratories nyse abt overall hold rating .
652,they sell,stock also flashing sell barchart trendspotter trading system .
653,they sell,traders hoping speculate abt short-term trajectory know short terms indicators stock averaged 40 sell average daily trading volume past 20 days 6796335 shares .
654,they buy,abt stock overall 0.25 buy signal considering medium term indicators 50-day average daily volume remained almost 5307256 shares .
655,they buy,also worth noting stock whose average daily volume 100 days prior writing 5238980 shares 67 buy basis long term indicators .
656,they buy,share price currently staying around first support level 67.53 .
657,they buy,next support placed zone 66.68 .
658,they buy,till time abt stock trades level bulls nothing fear .
659,they buy,momentum oscillators front rsi touched 42.12 daily chart may remain cause concern .
660,they buy,price breaks 66.68 level closing basis may see profit booking stock may show weakness .
661,they buy,flipside hitting 69.35 mark may result pull-back move towards 70.31 level .
662,they buy,abbott laboratories abt projected climb 6.48 percent next 12 months according price target estimates compiled finviz .
663,they buy,meanwhile set 86-month high price target .
664,they buy,represents whopping 25.77 percent increase shares trading today .
665,they buy,12-month median price target assigned analysts stands 73 represents return potential 6.76 percent compared closing price stock 68.38 thursday october 11. lowest price target stock 57 slightly percent abt current share price .
666,they buy,rundown insider trading activity sense abbott laboratories nyse abt .
667,they buy,earliest insider trade took place 09/20/2018 .
668,they sell,blaser brian j parted total 58.2 thousand shares company average share price 68.79 .
669,they buy,total sales set 4 million .
670,they buy,transaction executive vice president account balance stood 136.82 thousand shares .
671,they buy,stock grew 0.19 percent since insider sale .
672,they sell,08/29/2018 lane andrew h executive vice president sold 9.1 thousand shares price per share 67.11 .
673,they buy,removed 610.5 thousand shares insider fortune stock saw 2.7 percent rally value since news became public .
674,they buy,transaction left 27.83 thousand shares executive vice president account .
675,they buy,08/29/2018 senior vice president contreras jaime performed sale transaction worth 6.39 million .
676,they buy,sale 66.74 eliminated 95.79 thousand shares insider portfolio position .
677,they buy,meanwhile shares recorded 3.27 percent increase since transaction reported .
678,they buy,insider left 127.11 thousand shares remaining account .
679,they sell,contreras jaime performs senior vice president job sold 64.27 thousand shares 4.3 million .
680,they buy,disposal occurred 08/29/2018 priced 66.84 per share .
681,they buy,share price soared 3.11 percent since reporting date .
682,they buy,contreras jaime left stake 141.84 thousand abt stock worth 9.7 million insider selling .
683,they buy,abt shares dropped points percent thursday 68.38 heavy trade volume 11.92 million shares .
684,they buy,opening session 68.92 shares went high 69.465 low 67.65 range within stock price traded throughout day .
685,they buy,firm left market cap 120 billion 1.76 billion shares outstanding .
686,they buy,abbott laboratories abt stock gained 2.11 percent market value 21 trading days .
687,they buy,analysts bernstein assumed coverage abbott laboratories nyse abt outperform recommendation according opinion released june 27. citigroup analysts handed neutral rating abt stock lifted target price shares flash note investors january 30. price target raised 59 64 .
688,they buy,citigroup analysts launched coverage abt stock neutral rating according flash note investors january 30. analysts william blair issued upgrade mkt perform outperform stock research note dated back january 25 .
689,they buy,abt stock trailing 3-year beta 1.47 offering possibility higher rate return also posing risk .
690,they buy,portion company profit allocated outstanding share common stock 1.31 share trailing twelve months .
691,they buy,stock value surged 19.82 percent year date ytd rise 25.61 percent 12 month time .
692,they buy,company shares still trade percent away 1-year high 74.15 27.55 percent 52-week low 53.61 .
693,they sell,average consensus rating company 1.8 scale 5 equates unanimous sell rating .
694,they buy,short mean analyst recommendations calling stock buy .
695,they buy,shares abbott laboratories abt trading p/e ratio 54.64 times earnings reported past 12 months .
696,they buy,industry abt operates average p/e 38.68. p/e ratio went low 25.95x high 55.06 5-year span .
697,they buy,sporting 4.07 price-to-sales ratio .
698,they buy,compare industry average p/s 6.95 .
699,they buy,57.9 percent gross profit margin abbott laboratories operating margin sits 10.1 percent .
700,they buy,along net profit margin 3.1 percent .
701,they buy,analysts forecasting revenue climb 12 percent 7.65b next fiscal quarter earnings seen soaring nearly 13.64 percent 0.75 per share .
702,they buy,history shown shares abbott laboratories gone 18 different earnings reaction days predicted add 0.02 percent company reports upcoming earnings .
703,they buy,last reported earnings results earned 0.73 per share better 0.71 adjusted expected thomson reuters consensus estimate .
704,they buy,revenue 7.77b better 7.71b analysts expected .
705,they buy,earnings estimated increase 44.6 percent year 12.02 percent next year continue increase 11.84 percent annually next 5 years .
706,they buy,ky skyscr adsbygoogle window.adsbygoogle .push massmutual trust co. fsb adv reduced stake abbott laboratories nyse abt 9.1 second quarter according company recent 13f filing securities exchange commission .
707,they buy,"institutional investor owned 69,211 shares healthcare product maker stock selling 6,896 shares quarter ."
708,they buy,"massmutual trust co. fsb adv holdings abbott laboratories worth 4,221,000 recent filing securities exchange commission ."
709,they buy,several institutional investors hedge funds also recently modified holdings company .
710,they buy,waters parkerson co. llc increased stake shares abbott laboratories 0.4 first quarter .
711,they buy,"waters parkerson co. llc owns 523,452 shares healthcare product maker stock valued 31,365,000 buying additional 1,902 shares last quarter ."
712,they buy,exencial wealth advisors llc increased stake shares abbott laboratories 10.7 first quarter .
713,they buy,"exencial wealth advisors llc owns 47,756 shares healthcare product maker stock valued 2,862,000 buying additional 4,614 shares last quarter ."
714,they buy,usca ria llc increased stake shares abbott laboratories 16.3 first quarter .
715,they buy,"usca ria llc owns 21,394 shares healthcare product maker stock valued 1,282,000 buying additional 2,995 shares last quarter ."
716,they buy,venturi wealth management llc increased stake shares abbott laboratories 18.7 first quarter .
717,they buy,"venturi wealth management llc owns 12,695 shares healthcare product maker stock valued 761,000 buying additional 2,000 shares last quarter ."
718,they buy,finally sector gamma increased stake shares abbott laboratories 2.4 first quarter .
719,they buy,"sector gamma owns 1,105,642 shares healthcare product maker stock valued 66,250,000 buying additional 25,800 shares last quarter ."
720,they buy,72.16 stock currently owned hedge funds institutional investors .
721,they buy,abt stock traded 0.54 midday trading thursday reaching 68.38 .
722,they buy,"stock trading volume 11,944,300 shares compared average volume 5,995,051. company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. firm market cap 128.70 billion price-to-earnings ratio 27.72 peg ratio 2.05 beta 1.49. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
723,they buy,abbott laboratories nyse abt last announced quarterly earnings data wednesday july 18th .
724,they buy,healthcare product maker reported 0.73 eps quarter topping zacks consensus estimate 0.71 0.02 .
725,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
726,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
727,they buy,company revenue 17.0 year-over-year basis .
728,they buy,period last year company earned 0.62 earnings per share .
729,they sell,sell-side analysts predict abbott laboratories post 2.88 earnings per share current fiscal year .
730,they buy,business also recently announced quarterly dividend paid thursday november 15th .
731,they buy,shareholders record monday october 15th issued dividend 0.28 per share .
732,they buy,represents 1.12 dividend annualized basis yield 1.64 .
733,they buy,ex-dividend date dividend friday october 12th .
734,they buy,abbott laboratories dividend payout ratio dpr currently 44.80 .
735,they sell,"abbott laboratories news insider daniel gesua sive salvadori sold 5,000 shares firm stock transaction dated friday september 28th ."
736,they sell,"stock sold average price 73.39 total transaction 366,950.00 ."
737,they buy,"following transaction insider owns 93,321 shares company valued 6,848,828.19 ."
738,they buy,sale disclosed document filed sec available link .
739,they sell,"also insider michael j. pederson sold 1,050 shares firm stock transaction dated tuesday july 24th ."
740,they sell,"stock sold average price 63.43 total value 66,601.50 ."
741,they buy,"following transaction insider owns 79,467 shares company valued approximately 5,040,591.81 ."
742,they buy,disclosure sale found .
743,they sell,"last 90 days insiders sold 155,321 shares company stock worth 10,492,583 ."
744,they buy,company insiders 0.74 company stock .
745,they buy,abt subject number research reports .
746,they buy,sanford c. bernstein initiated coverage abbott laboratories research note wednesday june 27th .
747,they buy,issued outperform rating 73.00 target price company .
748,they buy,stifel nicolaus raised target price abbott laboratories 71.00 72.00 gave company buy rating research note thursday july 19th .
749,they buy,zacks investment research upgraded abbott laboratories hold rating buy rating set 70.00 target price company research note thursday july 19th .
750,they buy,royal bank canada restated buy rating issued 70.00 target price shares abbott laboratories research note thursday july 19th .
751,they buy,finally wells fargo co raised target price abbott laboratories 77.00 80.00 gave company outperform rating research note monday september 24th .
752,they sell,one research analyst rated stock sell rating four assigned hold rating fifteen issued buy rating stock .
753,they buy,company presently consensus rating buy consensus price target 73.17 .
754,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
755,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
756,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
757,they buy,bed bath beyond sees unusually large options volume nasdaq bbby abbott laboratories nyse abt upgraded zacks investment research hold rating buy rating report released tuesday september 18th .
758,they buy,brokerage presently 77.00 target price healthcare product maker stock .
759,they buy,zacks investment research price objective suggests potential upside 12.61 company previous close .
760,they buy,according zacks past year abbott outperforming industry .
761,they buy,upbeat strength across segments last reported quarter .
762,they buy,within structural heart worldwide strong uptake mitraclip therapy improves following recent fda approval next-generation version .
763,they buy,apart synergies alere consolidation form revenues rapid diagnostics driving growth .
764,they buy,meanwhile emerging market performance extremely promising .
765,they buy,company hogging limelight within diabetic care progress freestyle libre .
766,they buy,abbott branded generics model also expected intensify epd arm key emerging countries .
767,they buy,flip side sluggish vascular business continues dent growth .
768,they buy,however fda approval xience sierra coronary stent system well reimbursement approval japan help abbott revive dull vascular business .
769,they buy,equities research analysts also issued reports stock .
770,they buy,royal bank canada reiterated buy rating set 70.00 target price shares abbott laboratories report thursday july 19th .
771,they buy,stifel nicolaus increased target price shares abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
772,they buy,finally sanford c. bernstein assumed coverage shares abbott laboratories report wednesday june 27th .
773,they buy,set outperform rating 73.00 target price stock .
774,they sell,one equities research analyst rated stock sell rating four assigned hold rating fifteen given buy rating company .
775,they buy,company average rating buy consensus target price 73.17 .
776,they buy,shares abt stock traded 0.54 trading hours tuesday hitting 68.38 .
777,they buy,"company trading volume 11,920,376 shares compared average volume 5,994,929. company debt-to-equity ratio 0.64 quick ratio 1.16 current ratio 1.58. abbott laboratories fifty-two week low 53.61 fifty-two week high 74.15 ."
778,they buy,firm market cap 128.70 billion p/e ratio 27.72 p/e/g ratio 2.05 beta 1.49 .
779,they buy,abbott laboratories nyse abt last released earnings results wednesday july 18th .
780,they buy,healthcare product maker reported 0.73 earnings per share eps quarter topping zacks consensus estimate 0.71 0.02 .
781,they buy,company revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
782,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
783,they buy,firm quarterly revenue 17.0 year-over-year basis .
784,they buy,period prior year business earned 0.62 eps .
785,they buy,group research analysts predict abbott laboratories post 2.88 eps current fiscal year .
786,they sell,"related news insider daniel gesua sive salvadori sold 5,000 shares stock transaction friday september 28th ."
787,they sell,"shares sold average price 73.39 total value 366,950.00 ."
788,they buy,"following transaction insider directly owns 93,321 shares company stock valued approximately 6,848,828.19 ."
789,they buy,transaction disclosed legal filing securities exchange commission available link .
790,they sell,"also svp sharon j. bracken sold 1,732 shares stock transaction friday september 28th ."
791,they sell,"shares sold average price 73.35 total transaction 127,042.20 ."
792,they buy,"following completion transaction senior vice president directly owns 39,229 shares company valued 2,877,447.15 ."
793,they buy,disclosure sale found .
794,they sell,"insiders sold total 155,321 shares company stock worth 10,492,583 last ninety days ."
795,they buy,insiders 0.74 company stock .
796,they sell,hedge funds institutional investors recently bought sold shares stock .
797,they buy,blackrock inc. grew position abbott laboratories 3.7 2nd quarter .
798,they buy,"blackrock inc. owns 116,149,740 shares healthcare product maker stock worth 7,083,972,000 purchasing additional 4,153,157 shares last quarter ."
799,they buy,morgan stanley grew position abbott laboratories 33.1 2nd quarter .
800,they buy,"morgan stanley owns 21,218,276 shares healthcare product maker stock worth 1,294,103,000 purchasing additional 5,274,307 shares last quarter ."
801,they buy,janus henderson group plc grew position abbott laboratories 12.0 2nd quarter .
802,they buy,"janus henderson group plc owns 13,708,172 shares healthcare product maker stock worth 836,067,000 purchasing additional 1,468,430 shares last quarter ."
803,they buy,dimensional fund advisors lp grew position abbott laboratories 0.7 2nd quarter .
804,they buy,"dimensional fund advisors lp owns 9,477,591 shares healthcare product maker stock worth 578,069,000 purchasing additional 67,093 shares last quarter ."
805,they buy,finally franklin resources inc. grew position abbott laboratories 5.2 1st quarter .
806,they buy,"franklin resources inc. owns 9,042,686 shares healthcare product maker stock worth 541,838,000 purchasing additional 446,071 shares last quarter ."
807,they buy,72.16 stock currently owned hedge funds institutional investors .
808,they buy,"get free copy zacks research report abbott laboratories abt information research offerings zacks investment research visit zacks.com keyword abbott laboratories nyse abt abt medical,00282410 upgrade zacks investment researchratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
809,they buy,dz bank reiterates neutral rating zalando zldsf benson investment management company inc. purchased new position shares abbott laboratories nyse abt 3rd quarter according recent disclosure securities exchange commission .
810,they buy,"firm purchased 40,750 shares healthcare product maker stock valued approximately 2,989,000 ."
811,they buy,abbott laboratories makes 2.2 benson investment management company inc. portfolio making stock 24th biggest position .
812,they buy,several institutional investors hedge funds also modified holdings abt .
813,they buy,"atlantic trust llc acquired new stake shares abbott laboratories second quarter worth 104,000 ."
814,they buy,"rainier group investment advisory llc acquired new stake shares abbott laboratories first quarter worth 114,000 ."
815,they buy,"fny investment advisers llc acquired new stake shares abbott laboratories second quarter worth 118,000 ."
816,they buy,"fort l.p. acquired new stake shares abbott laboratories second quarter worth 119,000 ."
817,they buy,finally security national bank dak lifted holdings shares abbott laboratories 72.0 second quarter .
818,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 buying additional 878 shares last quarter ."
819,they buy,72.16 stock owned institutional investors .
820,they sell,"related news svp jaime contreras sold 64,268 shares abbott laboratories stock transaction occurred wednesday august 29th ."
821,they sell,"stock sold average price 66.84 total value 4,295,673.12 ."
822,they buy,"following transaction senior vice president directly owns 125,471 shares company stock valued 8,386,481.64 ."
823,they buy,transaction disclosed legal filing sec available hyperlink .
824,they sell,"also svp sharon j. bracken sold 1,732 shares abbott laboratories stock transaction occurred friday september 28th ."
825,they sell,"stock sold average price 73.35 total value 127,042.20 ."
826,they buy,"following completion transaction senior vice president directly owns 39,229 shares company valued 2,877,447.15 ."
827,they buy,disclosure sale found .
828,they sell,"last ninety days insiders sold 155,321 shares company stock worth 10,492,583 ."
829,they buy,0.74 stock owned insiders .
830,they buy,shares abt stock traded 0.48 mid-day trading thursday reaching 68.44 .
831,they buy,"1,754,277 shares stock traded hands compared average volume 5,964,736. abbott laboratories 1-year low 53.61 1-year high 74.15 ."
832,they buy,firm market capitalization 128.70 billion price-to-earnings ratio 27.72 peg ratio 2.05 beta 1.49. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
833,they buy,abbott laboratories nyse abt last announced quarterly earnings results wednesday july 18th .
834,they buy,healthcare product maker reported 0.73 eps quarter beating zacks consensus estimate 0.71 0.02 .
835,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
836,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
837,they buy,business revenue quarter 17.0 year-over-year basis .
838,they buy,period last year firm posted 0.62 earnings per share .
839,they sell,average sell-side analysts predict abbott laboratories post 2.88 earnings per share current fiscal year .
840,they buy,business also recently disclosed quarterly dividend paid thursday november 15th .
841,they buy,investors record monday october 15th paid 0.28 dividend .
842,they buy,represents 1.12 dividend annualized basis dividend yield 1.64 .
843,they buy,ex-dividend date dividend friday october 12th .
844,they buy,abbott laboratories dividend payout ratio currently 44.80 .
845,they buy,number equities research analysts recently weighed abt shares .
846,they buy,zacks investment research raised abbott laboratories hold rating buy rating set 77.00 target price company report tuesday september 18th .
847,they buy,wells fargo co raised price target abbott laboratories 77.00 80.00 gave stock outperform rating research report monday september 24th .
848,they buy,raymond james raised price target abbott laboratories 72.00 77.00 gave stock outperform rating research report monday september 24th .
849,they buy,stifel nicolaus raised price target abbott laboratories 71.00 72.00 gave stock buy rating research report thursday july 19th .
850,they buy,finally sanford c. bernstein started coverage abbott laboratories research report wednesday june 27th .
851,they buy,issued outperform rating 73.00 price target stock .
852,they sell,one research analyst rated stock sell rating four assigned hold rating fifteen given buy rating company stock .
853,they buy,company currently consensus rating buy consensus price target 73.17 .
854,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
855,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
856,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
857,they buy,"hollencrest capital management purchases 78,840 shares blackrock muniyld california quty fd inc nyse mca abbott laboratories nyse abt subtracted trading price close recent session dropping previous closing price 71.29 68.92 ."
858,they buy,stock increased value last 7-day period experienced loss 3.48 past 30-day period .
859,they buy,past three months stock price grew 9.85 added 17.15 price last six months trading .
860,they buy,abt demonstrated yearly price gain 24.40 year-to-date ytd price performance 20.76 .
861,they buy,stock price changed compared 90-day low moved comparing 90-day high price .
862,they buy,quick look short medium long-term indicators .
863,they sell,according composite indicator trendspotter rated abt stock sell .
864,they sell,"short-term abbott laboratories abt 20-day average volume 6,502,345 shares short-term indicators sets abt stock 40 sell average basis ."
865,they buy,"medium-term abt stock 50-day average volume 5,151,870 shares medium-term indicators gave average rating 25 buy long-term period fb stock 100-day average volume 5,165,759 shares ."
866,they buy,average long-term indicators rated stock 67 buy .
867,they buy,overall picture short medium long-term indicators sets abt stock hold overall average signal calculated 13 indicators .
868,they buy,signal strength long-term measurement historical strength signal signal direction short-term 3-day measurement movement signal.
869,they buy,average basis .
870,they buy,recently multiple brokerages sent reports abt .
871,they buy,bernstein example initiated rating shares abbott laboratories outperform setting 73 price target shares company stock according research note wednesday june 27th 2018. citigroup reiterated target price stock 59 64 giving stock neutral rating stated research report tuesday january 30th 2018. william blair hand upgrade mkt perform outperform rating stock research note dated thursday january 25th 2018 .
872,they buy,news related abbott laboratories stock 74.78 shares abt held institutions .
873,they buy,"total number institutions held abt shares 2,214 according recent sec filling ."
874,they buy,"past quarter total 1,311,947,102 shares held institutions net change 697,603 shares ."
875,they sell,meantime 17 new institutions bought shares abbott laboratories first time 5 institutions sold holdings company common stock .
876,they buy,76 institutions increased investment abt stock 69 institutions decreased investment abbott laboratories abt stock last quarter .
877,they buy,adsbygoogle window.adsbygoogle .push nm side bar adsbygoogle window.adsbygoogle .push evanson asset management llc trimmed position shares abbott laboratories nyse abt 58.9 3rd quarter according company recent 13f filing sec .
878,they buy,"institutional investor owned 4,483 shares healthcare product maker stock selling 6,427 shares quarter ."
879,they buy,"evanson asset management llc holdings abbott laboratories worth 329,000 end recent quarter ."
880,they sell,number institutional investors also recently bought sold shares abt .
881,they buy,morgan stanley boosted position abbott laboratories 33.1 2nd quarter .
882,they buy,"morgan stanley owns 21,218,276 shares healthcare product maker stock valued 1,294,103,000 acquiring additional 5,274,307 shares last quarter ."
883,they buy,"charles schwab investment advisory inc. bought new stake abbott laboratories 2nd quarter valued approximately 275,697,000 ."
884,they buy,american century companies inc. boosted position abbott laboratories 417.9 2nd quarter .
885,they buy,"american century companies inc. owns 5,586,119 shares healthcare product maker stock valued 340,697,000 acquiring additional 4,507,553 shares last quarter ."
886,they buy,blackrock inc. boosted position abbott laboratories 3.7 2nd quarter .
887,they buy,"blackrock inc. owns 116,149,740 shares healthcare product maker stock valued 7,083,972,000 acquiring additional 4,153,157 shares last quarter ."
888,they buy,"finally swedbank bought new stake abbott laboratories 2nd quarter valued approximately 101,535,000 ."
889,they buy,72.16 stock currently owned institutional investors hedge funds .
890,they sell,"related news insider daniel gesua sive salvadori sold 5,000 shares business stock transaction occurred friday september 28th ."
891,they sell,"shares sold average price 73.39 total value 366,950.00 ."
892,they buy,"following completion transaction insider directly owns 93,321 shares company valued approximately 6,848,828.19 ."
893,they buy,sale disclosed document filed sec available hyperlink .
894,they sell,"also insider andrew h. lane sold 9,097 shares business stock transaction occurred wednesday august 29th ."
895,they sell,"stock sold average price 67.11 total transaction 610,499.67 ."
896,they buy,"following completion transaction insider owns 35,576 shares company stock valued 2,387,505.36 ."
897,they buy,disclosure sale found .
898,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last quarter ."
899,they buy,company insiders 0.74 company stock .
900,they buy,abt stock opened 68.92 thursday .
901,they buy,abbott laboratories 52-week low 53.61 52-week high 74.15 .
902,they buy,company market cap 128.70 billion pe ratio 27.57 price-to-earnings-growth ratio 2.05 beta 1.49. company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64 .
903,they buy,abbott laboratories nyse abt last released earnings results wednesday july 18th .
904,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating thomson reuters consensus estimate 0.71 0.02 .
905,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
906,they buy,firm revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
907,they sell,period last year business earned 0.62 earnings per share .
908,they buy,business revenue 17.0 year-over-year basis .
909,they sell,sell-side analysts predict abbott laboratories post 2.88 eps current year .
910,they buy,firm also recently announced quarterly dividend paid thursday november 15th .
911,they buy,stockholders record monday october 15th issued dividend 0.28 per share .
912,they buy,ex-dividend date dividend friday october 12th .
913,they buy,represents 1.12 annualized dividend dividend yield 1.63 .
914,they buy,abbott laboratories payout ratio 44.80 .
915,they buy,abbott laboratories profile want see hedge funds holding abt visit holdingschannel.com get latest 13f filings insider trades abbott laboratories nyse abt .
916,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
917,they buy,name required chicago trust co na reduced position shares abbott laboratories nyse abt 21.8 3rd quarter according recent filing securities exchange commission sec .
918,they buy,"fund owned 90,844 shares healthcare product maker stock selling 25,364 shares period ."
919,they buy,abbott laboratories accounts 2.7 chicago trust co na investment portfolio making stock 3rd largest position .
920,they buy,"chicago trust co na holdings abbott laboratories worth 6,664,000 end recent reporting period ."
921,they buy,several institutional investors also recently added reduced stakes business .
922,they buy,"atlantic trust llc acquired new stake shares abbott laboratories second quarter worth approximately 104,000 ."
923,they buy,"rainier group investment advisory llc acquired new stake shares abbott laboratories first quarter worth approximately 114,000 ."
924,they buy,"fny investment advisers llc acquired new stake shares abbott laboratories second quarter worth approximately 118,000 ."
925,they buy,"fort l.p. acquired new stake shares abbott laboratories second quarter worth approximately 119,000 ."
926,they buy,finally security national bank dak boosted position shares abbott laboratories 72.0 second quarter .
927,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 acquiring additional 878 shares last quarter ."
928,they buy,72.16 stock currently owned institutional investors .
929,they buy,several research firms recently issued reports abt .
930,they buy,royal bank canada reissued buy rating issued 70.00 target price shares abbott laboratories research report thursday july 19th .
931,they buy,stifel nicolaus raised target price shares abbott laboratories 71.00 72.00 gave stock buy rating research report thursday july 19th .
932,they buy,jpmorgan chase co. raised target price shares abbott laboratories 77.00 81.00 gave stock overweight rating research report monday .
933,they buy,zacks investment research cut shares abbott laboratories buy rating hold rating research report monday august 6th .
934,they buy,finally sanford c. bernstein assumed coverage shares abbott laboratories research report wednesday june 27th .
935,they buy,issued outperform rating 73.00 target price stock .
936,they sell,one equities research analyst rated stock sell rating four assigned hold rating fifteen given buy rating company stock .
937,they buy,company currently consensus rating buy average price target 72.78 .
938,they buy,shares abt stock opened 68.92 thursday .
939,they buy,company market cap 128.70 billion price-to-earnings ratio 27.57 price-to-earnings-growth ratio 2.05 beta 1.49. company debt-to-equity ratio 0.64 quick ratio 1.16 current ratio 1.58. abbott laboratories fifty-two week low 53.61 fifty-two week high 74.15 .
940,they buy,abbott laboratories nyse abt last announced quarterly earnings results wednesday july 18th .
941,they buy,healthcare product maker reported 0.73 earnings per share quarter beating analysts consensus estimates 0.71 0.02 .
942,they buy,firm revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
943,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
944,they buy,abbott laboratories revenue 17.0 compared quarter last year .
945,they buy,period previous year company posted 0.62 earnings per share .
946,they sell,group equities research analysts anticipate abbott laboratories post 2.88 earnings per share current fiscal year .
947,they buy,firm also recently declared quarterly dividend paid thursday november 15th .
948,they buy,shareholders record monday october 15th given dividend 0.28 per share .
949,they buy,ex-dividend date dividend friday october 12th .
950,they buy,represents 1.12 dividend annualized basis yield 1.63 .
951,they buy,abbott laboratories dividend payout ratio dpr 44.80 .
952,they buy,"abbott laboratories keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
953,they buy,russell investments group ltd. takes position oxford square capital corp oxsq analysts bernstein assumed coverage abbott laboratories nyse abt outperform recommendation according opinion released june 27. citigroup analysts handed neutral rating abt stock lifted target price shares flash note investors january 30. price target raised 59 64 .
954,they buy,citigroup analysts launched coverage abt stock neutral rating according flash note investors january 30. analysts william blair issued upgrade mkt perform outperform stock research note dated back january 25 .
955,they buy,watching trading activity corporate insiders become easier get sense abbott laboratories nyse abt prospects .
956,they buy,earliest insider trade took place 09/20/2018 .
957,they buy,blaser brian j parted total 58.2 thousand shares company average share price 68.79 .
958,they buy,total sales set 4 million .
959,they buy,transaction executive vice president account balance stood 136.82 thousand shares .
960,they buy,stock grew 0.19 percent since insider sale .
961,they sell,08/29/2018 lane andrew h executive vice president sold 9.1 thousand shares price per share 67.11 .
962,they buy,removed 610.5 thousand shares insider fortune stock saw 2.7 percent rally value since news became public .
963,they buy,transaction left 27.83 thousand shares executive vice president account .
964,they buy,08/29/2018 senior vice president contreras jaime performed sale transaction worth 6.39 million .
965,they buy,sale 66.74 eliminated 95.79 thousand shares insider portfolio position .
966,they buy,meanwhile shares recorded 3.27 percent increase since transaction reported .
967,they buy,insider left 127.11 thousand shares remaining account .
968,they sell,contreras jaime performs senior vice president job sold 64.27 thousand shares 4.3 million .
969,they buy,disposal occurred 08/29/2018 priced 66.84 per share .
970,they buy,share price soared 3.11 percent since reporting date .
971,they buy,contreras jaime left stake 141.84 thousand abt stock worth 9.78 million insider selling .
972,they buy,abbott laboratories abt expected jump 5.64 percent next 12 months according price target estimates compiled finviz .
973,they buy,meanwhile set 86-month high price target .
974,they buy,represents whopping 24.78 percent increase shares trading today .
975,they buy,12-month median price target assigned analysts stands 73 represents return potential 5.92 percent compared closing price stock 68.92 wednesday october 10. lowest price target stock 57 slightly percent abt current share price .
976,they buy,shares currently floating around first support level 68.06 .
977,they buy,next support placed zone 67.21 .
978,they buy,till time abt stock trades level bulls nothing fear .
979,they buy,momentum oscillators front rsi touched 44.82 daily chart may remain cause concern .
980,they buy,price breaks 67.21 level closing basis may see profit booking stock may show weakness .
981,they buy,flipside hitting 70.49 mark may result pull-back move towards 72.07 level .
982,they buy,abt shares dropped points percent wednesday 68.92 heavy trade volume 10.538 million shares .
983,they buy,opening session 71.05 shares went high 71.21 low 68.78 range within stock price traded throughout day .
984,they buy,firm left market cap 121 billion 1.76 billion shares outstanding .
985,they buy,abbott laboratories abt stock gained 3.48 percent market value 21 trading days .
986,they buy,abt stock trailing 3-year beta 1.47 offering possibility higher rate return also posing risk .
987,they buy,portion company profit allocated outstanding share common stock 1.31 share trailing twelve months .
988,they buy,stock value surged 20.76 percent year date ytd rise 24.4 percent 12 month time .
989,they buy,company shares still trade percent away 1-year high 74.15 28.56 percent 52-week low 53.61 .
990,they sell,average consensus rating company 1.8 scale 5 equates unanimous sell rating .
991,they buy,short mean analyst recommendations calling stock buy .
992,they buy,shares abbott laboratories abt trading p/e ratio 54.64 times earnings reported past 12 months .
993,they buy,industry abt operates average p/e 38.68. p/e ratio went low 25.95x high 55.06 5-year span .
994,they buy,sporting 4.1 price-to-sales ratio .
995,they buy,compare industry average p/s 6.95 .
996,they buy,57.9 percent gross profit margin abbott laboratories operating margin sits 10.1 percent .
997,they buy,along net profit margin 3.1 percent .
998,they buy,analysts forecasting revenue climb 12 percent 7.65b next fiscal quarter earnings seen soaring nearly 13.64 percent 0.75 per share .
999,they buy,history shown shares abbott laboratories gone 18 different earnings reaction days predicted add 0.02 percent company reports upcoming earnings .
1000,they buy,last reported earnings results earned 0.73 per share better 0.71 adjusted expected thomson reuters consensus estimate .
1001,they buy,revenue 7.77b better 7.71b analysts expected .
1002,they buy,earnings estimated increase 44.6 percent year 12.02 percent next year continue increase 11.84 percent annually next 5 years .
1003,they buy,ky skyscr adsbygoogle window.adsbygoogle .push bremer trust national association raised stake shares abbott laboratories nyse abt 18.7 third quarter according recent filing securities exchange commission sec .
1004,they buy,"fund owned 48,516 shares healthcare product maker stock acquiring additional 7,652 shares quarter ."
1005,they buy,abbott laboratories makes 0.9 bremer trust national association portfolio making stock 23rd biggest position .
1006,they buy,"bremer trust national association holdings abbott laboratories worth 3,559,000 recent filing securities exchange commission sec ."
1007,they sell,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c hedge funds institutional investors also recently bought sold shares company .
1008,they buy,"atlantic trust llc acquired new stake shares abbott laboratories second quarter worth 104,000 ."
1009,they buy,"rainier group investment advisory llc acquired new stake shares abbott laboratories first quarter worth 114,000 ."
1010,they buy,"fny investment advisers llc acquired new stake shares abbott laboratories second quarter worth 118,000 ."
1011,they buy,"fort l.p. acquired new stake shares abbott laboratories second quarter worth 119,000 ."
1012,they buy,finally security national bank dak raised holdings shares abbott laboratories 72.0 second quarter .
1013,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 purchasing additional 878 shares period ."
1014,they buy,hedge funds institutional investors 72.16 company stock .
1015,they buy,shares abt stock traded 0.15 trading hours tuesday reaching 71.29 .
1016,they buy,"stock trading volume 334,690 shares compared average volume 5,946,999. company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
1017,they buy,stock market cap 128.70 billion pe ratio 28.57 price-to-earnings-growth ratio 2.05 beta 1.49 .
1018,they buy,abbott laboratories nyse abt last released quarterly earnings data wednesday july 18th .
1019,they buy,healthcare product maker reported 0.73 earnings per share quarter topping zacks consensus estimate 0.71 0.02 .
1020,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1021,they buy,business revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1022,they buy,quarter last year company earned 0.62 eps .
1023,they buy,company revenue quarter 17.0 compared quarter last year .
1024,they buy,equities analysts forecast abbott laboratories post 2.88 eps current fiscal year .
1025,they buy,company also recently disclosed quarterly dividend paid thursday november 15th .
1026,they buy,investors record monday october 15th issued 0.28 dividend .
1027,they buy,ex-dividend date dividend friday october 12th .
1028,they buy,represents 1.12 dividend annualized basis dividend yield 1.57 .
1029,they buy,abbott laboratories dividend payout ratio dpr presently 44.80 .
1030,they sell,"related news insider brian j. blaser sold 58,200 shares stock transaction dated thursday september 20th ."
1031,they sell,"shares sold average price 68.79 total value 4,003,578.00 ."
1032,they buy,"following sale insider owns 184,918 shares company stock valued approximately 12,720,509.22 ."
1033,they buy,transaction disclosed filing sec accessed hyperlink .
1034,they sell,"also svp jaime contreras sold 64,268 shares stock transaction dated wednesday august 29th ."
1035,they sell,"stock sold average price 66.84 total transaction 4,295,673.12 ."
1036,they buy,"following completion sale senior vice president directly owns 125,471 shares company valued approximately 8,386,481.64 ."
1037,they buy,disclosure sale found .
1038,they sell,"last ninety days insiders sold 155,321 shares company stock worth 10,492,583 ."
1039,they buy,corporate insiders 0.74 company stock .
1040,they buy,abt topic number research reports .
1041,they buy,zacks investment research raised shares abbott laboratories hold rating buy rating set 77.00 target price stock report tuesday september 18th .
1042,they buy,wells fargo co increased target price shares abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
1043,they buy,stifel nicolaus increased target price shares abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
1044,they buy,sanford c. bernstein initiated coverage shares abbott laboratories report wednesday june 27th .
1045,they buy,set outperform rating 73.00 target price stock .
1046,they buy,finally raymond james increased target price shares abbott laboratories 72.00 77.00 gave stock outperform rating report monday september 24th .
1047,they sell,one investment analyst rated stock sell rating four issued hold rating fifteen issued buy rating company .
1048,they buy,abbott laboratories presently consensus rating buy average target price 72.78 .
1049,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
1050,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1051,they sell,"abbott laboratories nyse abt svp sharon j. bracken sold 1,732 shares business stock transaction dated friday september 28th ."
1052,they sell,"shares sold average price 73.35 total transaction 127,042.20 ."
1053,they buy,"following completion transaction senior vice president owns 39,229 shares company valued 2,877,447.15 ."
1054,they buy,transaction disclosed legal filing securities exchange commission accessed hyperlink .
1055,they buy,shares abt opened 68.92 thursday .
1056,they buy,firm market cap 128.70 billion price-to-earnings ratio 27.57 peg ratio 2.05 beta 1.49. company debt-to-equity ratio 0.64 current ratio 1.58 quick ratio 1.16. abbott laboratories twelve month low 53.61 twelve month high 74.15 .
1057,they buy,abbott laboratories nyse abt last announced quarterly earnings results wednesday july 18th .
1058,they buy,healthcare product maker reported 0.73 earnings per share quarter beating thomson reuters consensus estimate 0.71 0.02 .
1059,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1060,they buy,business revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1061,they buy,quarter prior year company posted 0.62 eps .
1062,they buy,firm revenue quarter 17.0 compared quarter last year .
1063,they buy,group equities research analysts forecast abbott laboratories post 2.88 eps current fiscal year .
1064,they buy,number brokerages recently commented abt .
1065,they buy,zacks investment research lowered shares abbott laboratories buy rating hold rating report tuesday july 31st .
1066,they buy,wells fargo co upped target price shares abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
1067,they buy,raymond james upped target price shares abbott laboratories 72.00 77.00 gave stock outperform rating report monday september 24th .
1068,they buy,jpmorgan chase co. increased price target shares abbott laboratories 77.00 81.00 gave stock overweight rating report monday .
1069,they buy,finally sanford c. bernstein started coverage shares abbott laboratories report wednesday june 27th .
1070,they buy,issued outperform rating 73.00 price target stock .
1071,they sell,one analyst rated stock sell rating four issued hold rating fifteen issued buy rating company stock .
1072,they buy,stock currently average rating buy consensus price target 72.78 .
1073,they sell,several large investors recently bought sold shares abt .
1074,they buy,"atlantic trust llc bought new position shares abbott laboratories 2nd quarter worth 104,000 ."
1075,they buy,"rainier group investment advisory llc bought new position shares abbott laboratories 1st quarter worth 114,000 ."
1076,they buy,"fny investment advisers llc bought new position shares abbott laboratories 2nd quarter worth 118,000 ."
1077,they buy,"fort l.p. bought new stake abbott laboratories 2nd quarter valued 119,000 ."
1078,they buy,finally security national bank dak increased stake abbott laboratories 72.0 2nd quarter .
1079,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock valued 128,000 purchasing additional 878 shares last quarter ."
1080,they buy,72.16 stock owned hedge funds institutional investors .
1081,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
1082,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1083,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 insider trading insider trades stocksratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1084,they buy,name required trust department mb financial bank n reduced stake abbott laboratories nyse abt 23.9 3rd quarter according company recent 13f filing securities exchange commission .
1085,they buy,"firm owned 22,320 shares healthcare product maker stock selling 7,008 shares period ."
1086,they buy,"trust department mb financial bank n holdings abbott laboratories worth 1,638,000 recent filing securities exchange commission ."
1087,they buy,google_ad_client ca-pub-0703139142419429 google_ad_slot 5621244306 google_ad_width 336 google_ad_height 280 c hedge funds also recently added reduced stakes company .
1088,they buy,"atlantic trust llc bought new stake abbott laboratories 2nd quarter worth approximately 104,000 ."
1089,they buy,"rainier group investment advisory llc acquired new position abbott laboratories 1st quarter worth 114,000 ."
1090,they buy,"fny investment advisers llc acquired new position abbott laboratories 2nd quarter worth 118,000 ."
1091,they buy,"fort l.p. acquired new position abbott laboratories 2nd quarter worth 119,000 ."
1092,they buy,finally security national bank dak lifted holdings abbott laboratories 72.0 2nd quarter .
1093,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 buying additional 878 shares last quarter ."
1094,they buy,institutional investors 72.16 company stock .
1095,they buy,abt topic several research reports .
1096,they buy,cowen upped price objective abbott laboratories 72.00 86.00 gave stock average rating report friday .
1097,they buy,zacks investment research downgraded abbott laboratories buy rating hold rating report wednesday september 19th .
1098,they buy,wells fargo co upped price objective abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
1099,they buy,raymond james increased price target abbott laboratories 72.00 77.00 gave company outperform rating research note monday september 24th .
1100,they buy,finally sanford c. bernstein initiated coverage abbott laboratories research note wednesday june 27th .
1101,they buy,issued outperform rating 73.00 price target stock .
1102,they sell,one investment analyst rated stock sell rating four given hold rating fifteen given buy rating company stock .
1103,they buy,company currently average rating buy average target price 72.78 .
1104,they buy,abt stock traded 0.15 trading hours tuesday reaching 71.29 .
1105,they buy,"359,937 shares stock exchanged compared average volume 5,946,999. stock market cap 128.70 billion pe ratio 28.57 price-to-earnings-growth ratio 2.05 beta 1.49. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64. abbott laboratories 12 month low 53.61 12 month high 74.15 ."
1106,they buy,abbott laboratories nyse abt last released earnings results wednesday july 18th .
1107,they buy,healthcare product maker reported 0.73 earnings per share eps quarter topping zacks consensus estimate 0.71 0.02 .
1108,they buy,firm revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1109,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
1110,they buy,company revenue 17.0 year-over-year basis .
1111,they buy,quarter prior year company earned 0.62 eps .
1112,they buy,average analysts forecast abbott laboratories post 2.88 earnings per share current fiscal year .
1113,they buy,company also recently announced quarterly dividend paid thursday november 15th .
1114,they buy,shareholders record monday october 15th issued dividend 0.28 per share .
1115,they buy,represents 1.12 dividend annualized basis yield 1.57 .
1116,they buy,ex-dividend date dividend friday october 12th .
1117,they buy,abbott laboratories dividend payout ratio dpr presently 44.80 .
1118,they sell,"news svp sharon j. bracken sold 1,732 shares firm stock transaction dated friday september 28th ."
1119,they sell,"stock sold average price 73.35 total value 127,042.20 ."
1120,they buy,"following completion transaction senior vice president owns 39,229 shares company valued approximately 2,877,447.15 ."
1121,they buy,sale disclosed filing securities exchange commission available hyperlink .
1122,they sell,"also insider daniel gesua sive salvadori sold 5,000 shares firm stock transaction dated friday september 28th ."
1123,they sell,"shares sold average price 73.39 total value 366,950.00 ."
1124,they buy,"following completion transaction insider owns 93,321 shares company stock valued approximately 6,848,828.19 ."
1125,they buy,disclosure sale found .
1126,they sell,"last quarter insiders sold 155,321 shares company stock valued 10,492,583 ."
1127,they buy,corporate insiders 0.74 company stock .
1128,they buy,want see hedge funds holding abt visit holdingschannel.com get latest 13f filings insider trades abbott laboratories nyse abt .
1129,they sell,google_ad_client ca-pub-0703139142419429 google_ad_slot 1418630638 google_ad_width 336 google_ad_height 280 abbott laboratories nyse abt downgraded zacks investment research hold rating sell rating note issued investors monday .
1130,they buy,according zacks worried abbott dull epd sales russia temporary disruption distribution channel dynamics .
1131,they buy,may continue third quarter .
1132,they buy,sluggish vascular arm continues dent growth .
1133,they buy,brighter note fda approval xience sierra well reimbursement approval japan help abbott revive dull vascular business .
1134,they buy,within structural heart worldwide strong uptake mitraclip improves following fda approval upgraded version .
1135,they buy,apart synergies alere consolidation form revenues rapid diagnostics driving growth .
1136,they buy,meanwhile emerging market performance promising .
1137,they buy,company hogging limelight within diabetic care growth freestyle libre .
1138,they buy,abbott branded generics model also expected intensify epd arm emerging countries .
1139,they buy,past year abbott outperforming industry .
1140,they buy,equities analysts also recently issued reports stock .
1141,they buy,royal bank canada reissued buy rating set 70.00 price target shares abbott laboratories research report thursday july 19th .
1142,they buy,jpmorgan chase co. lifted price target shares abbott laboratories 77.00 81.00 gave stock overweight rating research report monday .
1143,they buy,stifel nicolaus lifted price target shares abbott laboratories 71.00 72.00 gave stock buy rating research report thursday july 19th .
1144,they buy,sanford c. bernstein began coverage shares abbott laboratories research report wednesday june 27th .
1145,they buy,set outperform rating 73.00 price target stock .
1146,they buy,finally raymond james lifted price target shares abbott laboratories 72.00 77.00 gave stock outperform rating research report monday september 24th .
1147,they sell,one equities research analyst rated stock sell rating four given hold rating fifteen assigned buy rating stock .
1148,they buy,stock presently average rating buy consensus target price 72.78 .
1149,they buy,abbott laboratories nyse abt last announced quarterly earnings results wednesday july 18th .
1150,they buy,healthcare product maker reported 0.73 earnings per share quarter topping analysts consensus estimates 0.71 0.02 .
1151,they buy,company revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1152,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1153,they buy,business quarterly revenue 17.0 compared quarter last year .
1154,they sell,period last year firm posted 0.62 earnings per share .
1155,they buy,group equities analysts anticipate abbott laboratories post 2.88 earnings per share current fiscal year .
1156,they sell,"related news svp jaime contreras sold 64,268 shares business stock transaction wednesday august 29th ."
1157,they sell,"shares sold average price 66.84 total value 4,295,673.12 ."
1158,they buy,"following sale senior vice president directly owns 125,471 shares company stock valued approximately 8,386,481.64 ."
1159,they buy,transaction disclosed legal filing securities exchange commission available hyperlink .
1160,they sell,"also insider michael j. pederson sold 1,050 shares business stock transaction tuesday july 24th ."
1161,they sell,"shares sold average price 63.43 total transaction 66,601.50 ."
1162,they buy,"following completion sale insider directly owns 79,467 shares company valued 5,040,591.81 ."
1163,they buy,disclosure sale found .
1164,they sell,"insiders sold total 155,321 shares company stock worth 10,492,583 last ninety days ."
1165,they buy,0.74 stock currently owned insiders .
1166,they sell,number institutional investors hedge funds recently bought sold shares stock .
1167,they buy,ontario teachers pension plan board lifted position abbott laboratories 8.2 2nd quarter .
1168,they buy,"ontario teachers pension plan board owns 23,331 shares healthcare product maker stock worth 1,423,000 buying additional 1,762 shares last quarter ."
1169,they buy,"hrt financial llc bought new stake abbott laboratories 2nd quarter worth 206,000 ."
1170,they buy,american century companies inc. lifted position abbott laboratories 417.9 2nd quarter .
1171,they buy,"american century companies inc. owns 5,586,119 shares healthcare product maker stock worth 340,697,000 buying additional 4,507,553 shares last quarter ."
1172,they buy,baird financial group inc. lifted position abbott laboratories 0.8 2nd quarter .
1173,they buy,"baird financial group inc. owns 1,195,417 shares healthcare product maker stock worth 72,823,000 buying additional 9,229 shares last quarter ."
1174,they buy,"finally worldquant millennium quantitative strategies llc bought new stake abbott laboratories 2nd quarter worth 1,793,000 ."
1175,they buy,72.16 stock currently owned institutional investors hedge funds .
1176,they sell,"get free copy zacks research report abbott laboratories abt information research offerings zacks investment research visit zacks.com keyword abbott laboratories nyse abt abt medical,00282410 downgrade zacks investment researchratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1177,they buy,"zb zb reaches 24 hour trading volume 791,907.00 martin co. inc. tn raised position abbott laboratories nyse abt 3.1 second quarter according company recent disclosure securities exchange commission ."
1178,they buy,"firm owned 31,792 shares healthcare product maker stock purchasing additional 945 shares quarter ."
1179,they buy,"martin co. inc. tn holdings abbott laboratories worth 1,939,000 recent sec filing ."
1180,they buy,number hedge funds institutional investors also recently made changes positions abt .
1181,they buy,"rainier group investment advisory llc purchased new stake shares abbott laboratories first quarter worth 114,000 ."
1182,they buy,"fny investment advisers llc purchased new stake shares abbott laboratories second quarter worth 118,000 ."
1183,they buy,"fort l.p. purchased new stake shares abbott laboratories second quarter worth 119,000 ."
1184,they buy,security national bank dak increased position shares abbott laboratories 72.0 second quarter .
1185,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 acquiring additional 878 shares period ."
1186,they buy,"finally private ocean llc increased position shares abbott laboratories 9,868.2 first quarter ."
1187,they buy,"private ocean llc owns 2,193 shares healthcare product maker stock worth 131,000 acquiring additional 2,171 shares period ."
1188,they buy,72.16 stock currently owned institutional investors .
1189,they sell,"abbott laboratories news svp jaime contreras sold 64,268 shares company stock transaction wednesday august 29th ."
1190,they sell,"shares sold average price 66.84 total value 4,295,673.12 ."
1191,they buy,"following completion transaction senior vice president owns 125,471 shares company valued 8,386,481.64 ."
1192,they buy,transaction disclosed legal filing securities exchange commission accessible hyperlink .
1193,they sell,"also evp brian j. blaser sold 15,100 shares company stock transaction tuesday july 24th ."
1194,they sell,"shares sold average price 63.96 total transaction 965,796.00 ."
1195,they buy,"following completion transaction executive vice president owns 151,718 shares company stock valued approximately 9,703,883.28 ."
1196,they buy,disclosure sale found .
1197,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last 90 days ."
1198,they buy,0.74 stock currently owned insiders .
1199,they buy,shares abt stock traded 0.15 tuesday reaching 71.29 .
1200,they buy,"4,812,200 shares stock exchanged compared average volume 5,941,136. company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
1201,they buy,company market cap 128.70 billion p/e ratio 28.57 peg ratio 2.05 beta 1.49 .
1202,they buy,abbott laboratories nyse abt last released quarterly earnings data wednesday july 18th .
1203,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating consensus estimate 0.71 0.02 .
1204,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1205,they buy,company revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
1206,they buy,quarter prior year firm posted 0.62 earnings per share .
1207,they buy,abbott laboratories revenue quarter 17.0 year-over-year basis .
1208,they buy,average equities analysts forecast abbott laboratories post 2.88 eps current year .
1209,they buy,business also recently disclosed quarterly dividend paid thursday november 15th .
1210,they buy,shareholders record monday october 15th paid 0.28 dividend .
1211,they buy,ex-dividend date friday october 12th .
1212,they buy,represents 1.12 annualized dividend yield 1.57 .
1213,they buy,abbott laboratories dividend payout ratio presently 44.80 .
1214,they buy,"abbott laboratories profile keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1215,they buy,laboratory corp. america holdings nyse lh holdings increased advisors asset management inc .
1216,they sell,"abbott laboratories nyse abt svp sharon j. bracken sold 1,732 shares firm stock transaction occurred friday september 28th ."
1217,they sell,"stock sold average price 73.35 total transaction 127,042.20 ."
1218,they buy,"following sale senior vice president owns 39,229 shares company valued 2,877,447.15 ."
1219,they buy,sale disclosed document filed sec accessible sec website .
1220,they buy,abt traded 0.15 trading tuesday reaching 71.29 .
1221,they buy,"4,812,200 shares stock exchanged compared average volume 5,941,136. company market cap 128.70 billion price-to-earnings ratio 28.57 peg ratio 2.05 beta 1.49. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
1222,they buy,company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64 .
1223,they buy,abbott laboratories nyse abt last issued earnings results wednesday july 18th .
1224,they buy,healthcare product maker reported 0.73 earnings per share quarter topping zacks consensus estimate 0.71 0.02 .
1225,they buy,business revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
1226,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1227,they buy,firm revenue quarter 17.0 year-over-year basis .
1228,they buy,period previous year company earned 0.62 earnings per share .
1229,they buy,group research analysts forecast abbott laboratories post 2.88 earnings per share current year .
1230,they buy,number institutional investors hedge funds recently modified holdings stock .
1231,they buy,"atlantic trust llc bought new position abbott laboratories second quarter worth 104,000 ."
1232,they buy,"rainier group investment advisory llc bought new position abbott laboratories first quarter worth 114,000 ."
1233,they buy,"fny investment advisers llc bought new position abbott laboratories second quarter worth 118,000 ."
1234,they buy,"fort l.p. bought new position abbott laboratories second quarter worth 119,000 ."
1235,they buy,finally security national bank dak boosted position abbott laboratories 72.0 second quarter .
1236,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 purchasing additional 878 shares period ."
1237,they buy,institutional investors hedge funds 72.16 company stock .
1238,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 insider trading insider trades stocksratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1239,they buy,independent research analysts give apple nasdaq aapl 270.00 price target abbott laboratories abt probably climb 1.92 percent next 12 months according price target estimates compiled finviz .
1240,they buy,meanwhile set 86-month high price target .
1241,they buy,represents whopping 20.38 percent increase shares trading today .
1242,they buy,12-month median price target assigned analysts stands 73 represents return potential 2.18 percent compared closing price stock 71.44 monday october 08. lowest price target stock 57 slightly percent abt current share price .
1243,they buy,stock currently hovering around first support level 70.56 .
1244,they buy,next support placed zone 69.69 .
1245,they buy,till time abt stock trades level bulls nothing fear .
1246,they buy,momentum oscillators front rsi touched 60.64 daily chart may remain cause concern .
1247,they buy,price breaks 69.69 level closing basis may see profit booking stock may show weakness .
1248,they buy,flipside hitting 72.35 mark may result pull-back move towards 73.27 level .
1249,they buy,8th october abbott laboratories nyse abt shares ended lower volatile session .
1250,they buy,shares dropped points percent 71.44 heavy trade volume 5.512 million shares .
1251,they buy,opening session 71.58 shares went high 72.39 low 70.6 range within stock price traded throughout day .
1252,they buy,firm left market cap 126 billion 1.76 billion shares outstanding .
1253,they buy,abbott laboratories abt stock gained 7.9 percent market value 21 trading days .
1254,they buy,abt stock trailing 3-year beta 1.47 offering possibility higher rate return also posing risk .
1255,they buy,portion company profit allocated outstanding share common stock 1.31 share trailing twelve months .
1256,they buy,stock value surged 25.18 percent year date ytd rise 29.89 percent 12 month time .
1257,they buy,company shares still trade percent away 1-year high 74.15 33.26 percent 52-week low 53.61 .
1258,they sell,average consensus rating company 1.8 scale 5 equates unanimous sell rating .
1259,they buy,short mean analyst recommendations calling stock buy .
1260,they buy,shares abbott laboratories abt trading p/e ratio 84.45 times earnings reported past 12 months .
1261,they buy,industry abt operates average p/e 32.83. p/e ratio went low 25.95x high 210.52 5-year span .
1262,they buy,sporting 4.25 price-to-sales ratio .
1263,they buy,compare industry average p/s 7.37 .
1264,they buy,57.9 percent gross profit margin abbott laboratories operating margin sits 10.1 percent .
1265,they buy,along net profit margin 3.1 percent .
1266,they buy,let take look insider activity abbott laboratories nyse abt see pattern .
1267,they buy,earliest insider trade took place 09/28/2018 .
1268,they sell,salvadori daniel gesua sive parted total 5 thousand shares company average share price 73.39 .
1269,they buy,total sales set 366.95 thousand .
1270,they buy,transaction executive vice president account balance stood 88.52 thousand shares .
1271,they buy,stock lost percent since insider sale .
1272,they sell,09/28/2018 bracken sharon j senior vice president sold 1.73 thousand shares price per share 73.35 .
1273,they buy,removed 127.04 thousand shares insider fortune stock saw percent retreat value since news became public .
1274,they buy,transaction left 39.78 thousand shares senior vice president account .
1275,they buy,09/20/2018 executive vice president blaser brian j performed sale transaction worth 4 million .
1276,they buy,sale 68.79 eliminated 58.2 thousand shares insider portfolio position .
1277,they buy,meanwhile shares recorded 3.85 percent increase since transaction reported .
1278,they buy,insider left 136.82 thousand shares remaining account .
1279,they sell,lane andrew h performs executive vice president job sold 9.1 thousand shares 610.5 thousand .
1280,they buy,disposal occurred 08/29/2018 priced 67.11 per share .
1281,they buy,share price soared 6.45 percent since reporting date .
1282,they buy,lane andrew h left stake 27.83 thousand abt stock worth 1.99 million insider selling .
1283,they buy,ky skyscr adsbygoogle window.adsbygoogle .push posted terry king oct 9th 2018 comments trust department mb financial bank n reduced stake abbott laboratories nyse abt 23.9 3rd quarter according company recent 13f filing securities exchange commission .
1284,they buy,"firm owned 22,320 shares healthcare product maker stock selling 7,008 shares period ."
1285,they buy,"trust department mb financial bank n holdings abbott laboratories worth 1,638,000 recent filing securities exchange commission ."
1286,they buy,hedge funds also recently added reduced stakes company .
1287,they buy,"atlantic trust llc bought new stake abbott laboratories 2nd quarter worth approximately 104,000 ."
1288,they buy,"rainier group investment advisory llc acquired new position abbott laboratories 1st quarter worth 114,000 ."
1289,they buy,"fny investment advisers llc acquired new position abbott laboratories 2nd quarter worth 118,000 ."
1290,they buy,"fort l.p. acquired new position abbott laboratories 2nd quarter worth 119,000 ."
1291,they buy,finally security national bank dak lifted holdings abbott laboratories 72.0 2nd quarter .
1292,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 buying additional 878 shares last quarter ."
1293,they buy,institutional investors 72.16 company stock .
1294,they buy,abt topic several research reports .
1295,they buy,cowen upped price objective abbott laboratories 72.00 86.00 gave stock average rating report friday .
1296,they buy,zacks investment research downgraded abbott laboratories buy rating hold rating report wednesday september 19th .
1297,they buy,wells fargo co upped price objective abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
1298,they buy,raymond james increased price target abbott laboratories 72.00 77.00 gave company outperform rating research note monday september 24th .
1299,they buy,finally sanford c. bernstein initiated coverage abbott laboratories research note wednesday june 27th .
1300,they buy,issued outperform rating 73.00 price target stock .
1301,they sell,one investment analyst rated stock sell rating four given hold rating fifteen given buy rating company stock .
1302,they buy,company currently average rating buy average target price 72.78 .
1303,they buy,abbott laboratories nyse abt last released earnings results wednesday july 18th .
1304,they buy,healthcare product maker reported 0.73 earnings per share eps quarter topping zacks consensus estimate 0.71 0.02 .
1305,they buy,firm revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1306,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
1307,they buy,company revenue 17.0 year-over-year basis .
1308,they buy,quarter prior year company earned 0.62 eps .
1309,they buy,average analysts forecast abbott laboratories post 2.88 earnings per share current fiscal year .
1310,they buy,company also recently announced quarterly dividend paid thursday november 15th .
1311,they buy,shareholders record monday october 15th issued dividend 0.28 per share .
1312,they buy,represents 1.12 dividend annualized basis yield 1.57 .
1313,they buy,ex-dividend date dividend friday october 12th .
1314,they buy,abbott laboratories dividend payout ratio dpr presently 44.80 .
1315,they sell,"news svp sharon j. bracken sold 1,732 shares firm stock transaction dated friday september 28th ."
1316,they sell,"stock sold average price 73.35 total value 127,042.20 ."
1317,they buy,"following completion transaction senior vice president owns 39,229 shares company valued approximately 2,877,447.15 ."
1318,they buy,sale disclosed filing securities exchange commission available hyperlink .
1319,they sell,"also insider daniel gesua sive salvadori sold 5,000 shares firm stock transaction dated friday september 28th ."
1320,they sell,"shares sold average price 73.39 total value 366,950.00 ."
1321,they buy,"following completion transaction insider owns 93,321 shares company stock valued approximately 6,848,828.19 ."
1322,they buy,disclosure sale found .
1323,they sell,"last quarter insiders sold 155,321 shares company stock valued 10,492,583 ."
1324,they buy,corporate insiders 0.74 company stock .
1325,they buy,want see hedge funds holding abt visit holdingschannel.com get latest 13f filings insider trades abbott laboratories nyse abt .
1326,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1327,they buy,"state alaska department revenue purchases 2,125 shares medtronic plc mdt united capital management ks inc. invests 1.04 million abbott laboratories abt stock name required mail published required bremer trust national association raised stake shares abbott laboratories nyse abt 18.7 third quarter according recent filing securities exchange commission sec ."
1328,they buy,"fund owned 48,516 shares healthcare product maker stock acquiring additional 7,652 shares quarter ."
1329,they buy,abbott laboratories makes 0.9 bremer trust national association portfolio making stock 23rd biggest position .
1330,they buy,"bremer trust national association holdings abbott laboratories worth 3,559,000 recent filing securities exchange commission sec ."
1331,they sell,hedge funds institutional investors also recently bought sold shares company .
1332,they buy,"atlantic trust llc acquired new stake shares abbott laboratories second quarter worth 104,000 ."
1333,they buy,"rainier group investment advisory llc acquired new stake shares abbott laboratories first quarter worth 114,000 ."
1334,they buy,"fny investment advisers llc acquired new stake shares abbott laboratories second quarter worth 118,000 ."
1335,they buy,"fort l.p. acquired new stake shares abbott laboratories second quarter worth 119,000 ."
1336,they buy,finally security national bank dak raised holdings shares abbott laboratories 72.0 second quarter .
1337,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 purchasing additional 878 shares period ."
1338,they buy,hedge funds institutional investors 72.16 company stock .
1339,they buy,shares abt stock traded 0.15 trading hours tuesday reaching 71.29 .
1340,they buy,"stock trading volume 334,690 shares compared average volume 5,946,999. company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. abbott laboratories twelve month low 53.61 twelve month high 74.15 ."
1341,they buy,stock market cap 128.70 billion pe ratio 28.57 price-to-earnings-growth ratio 2.05 beta 1.49 .
1342,they buy,abbott laboratories nyse abt last released quarterly earnings data wednesday july 18th .
1343,they buy,healthcare product maker reported 0.73 earnings per share quarter topping zacks consensus estimate 0.71 0.02 .
1344,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1345,they buy,business revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1346,they buy,quarter last year company earned 0.62 eps .
1347,they buy,company revenue quarter 17.0 compared quarter last year .
1348,they sell,equities analysts forecast abbott laboratories post 2.88 eps current fiscal year .
1349,they buy,company also recently disclosed quarterly dividend paid thursday november 15th .
1350,they buy,investors record monday october 15th issued 0.28 dividend .
1351,they buy,ex-dividend date dividend friday october 12th .
1352,they buy,represents 1.12 dividend annualized basis dividend yield 1.57 .
1353,they buy,abbott laboratories dividend payout ratio dpr presently 44.80 .
1354,they sell,"related news insider brian j. blaser sold 58,200 shares stock transaction dated thursday september 20th ."
1355,they sell,"shares sold average price 68.79 total value 4,003,578.00 ."
1356,they buy,"following sale insider owns 184,918 shares company stock valued approximately 12,720,509.22 ."
1357,they buy,transaction disclosed filing sec accessed hyperlink .
1358,they sell,"also svp jaime contreras sold 64,268 shares stock transaction dated wednesday august 29th ."
1359,they sell,"stock sold average price 66.84 total transaction 4,295,673.12 ."
1360,they buy,"following completion sale senior vice president directly owns 125,471 shares company valued approximately 8,386,481.64 ."
1361,they buy,disclosure sale found .
1362,they sell,"last ninety days insiders sold 155,321 shares company stock worth 10,492,583 ."
1363,they buy,corporate insiders 0.74 company stock .
1364,they buy,abt topic number research reports .
1365,they buy,zacks investment research raised shares abbott laboratories hold rating buy rating set 77.00 target price stock report tuesday september 18th .
1366,they buy,wells fargo co increased target price shares abbott laboratories 77.00 80.00 gave stock outperform rating report monday september 24th .
1367,they buy,stifel nicolaus increased target price shares abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
1368,they buy,sanford c. bernstein initiated coverage shares abbott laboratories report wednesday june 27th .
1369,they buy,set outperform rating 73.00 target price stock .
1370,they buy,finally raymond james increased target price shares abbott laboratories 72.00 77.00 gave stock outperform rating report monday september 24th .
1371,they sell,one investment analyst rated stock sell rating four issued hold rating fifteen issued buy rating company .
1372,they buy,abbott laboratories presently consensus rating buy average target price 72.78 .
1373,they buy,abbott laboratories abbott laboratories discovers develops manufactures sells health care products worldwide .
1374,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1375,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abt receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1376,they buy,unilever n.v. ul shares bought beese fulmer investment management inc .
1377,they buy,park national corp oh grew position abbott laboratories nyse abt 0.8 3rd quarter according recent filing securities exchange commission .
1378,they buy,"firm owned 553,887 shares healthcare product maker stock buying additional 4,149 shares period ."
1379,they buy,abbott laboratories makes 2.2 park national corp oh portfolio making stock 9th largest position .
1380,they buy,"park national corp oh holdings abbott laboratories worth 40,633,000 end recent quarter ."
1381,they buy,hedge funds also recently made changes positions company .
1382,they buy,ontario teachers pension plan board raised holdings shares abbott laboratories 8.2 2nd quarter .
1383,they buy,"ontario teachers pension plan board owns 23,331 shares healthcare product maker stock valued 1,423,000 purchasing additional 1,762 shares period ."
1384,they buy,"hrt financial llc bought new position shares abbott laboratories second quarter worth approximately 206,000 ."
1385,they buy,american century companies inc. increased holdings shares abbott laboratories 417.9 second quarter .
1386,they buy,"american century companies inc. owns 5,586,119 shares healthcare product maker stock worth 340,697,000 purchasing additional 4,507,553 shares period ."
1387,they buy,baird financial group inc. increased holdings shares abbott laboratories 0.8 second quarter .
1388,they buy,"baird financial group inc. owns 1,195,417 shares healthcare product maker stock worth 72,823,000 purchasing additional 9,229 shares period ."
1389,they buy,"finally worldquant millennium quantitative strategies llc bought new position shares abbott laboratories second quarter worth approximately 1,793,000 ."
1390,they buy,72.16 stock owned institutional investors .
1391,they sell,"abbott laboratories news insider michael j. pederson sold 1,050 shares abbott laboratories stock transaction tuesday july 24th ."
1392,they sell,"shares sold average price 63.43 total value 66,601.50 ."
1393,they buy,"following completion sale insider directly owns 79,467 shares company stock valued 5,040,591.81 ."
1394,they buy,transaction disclosed legal filing sec available sec website .
1395,they sell,"also svp jaime contreras sold 64,268 shares abbott laboratories stock transaction wednesday august 29th ."
1396,they sell,"shares sold average price 66.84 total transaction 4,295,673.12 ."
1397,they buy,"following completion sale senior vice president directly owns 125,471 shares company stock valued 8,386,481.64 ."
1398,they buy,disclosure sale found .
1399,they sell,"insiders sold 155,321 shares company stock valued 10,492,583 last three months ."
1400,they buy,0.74 stock owned insiders .
1401,they buy,abbott laboratories nyse abt last released quarterly earnings results wednesday july 18th .
1402,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating thomson reuters consensus estimate 0.71 0.02 .
1403,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1404,they buy,firm revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
1405,they sell,quarter last year firm earned 0.62 earnings per share .
1406,they buy,company revenue quarter 17.0 year-over-year basis .
1407,they sell,group sell-side analysts forecast abbott laboratories post 2.88 earnings per share current fiscal year .
1408,they buy,company also recently announced quarterly dividend paid thursday november 15th .
1409,they buy,investors record monday october 15th paid dividend 0.28 per share .
1410,they buy,represents 1.12 dividend annualized basis yield 1.58 .
1411,they buy,ex-dividend date dividend friday october 12th .
1412,they buy,abbott laboratories dividend payout ratio presently 44.80 .
1413,they buy,abt topic several analyst reports .
1414,they sell,zacks investment research lowered shares abbott laboratories hold rating sell rating research report monday .
1415,they buy,jpmorgan chase co. increased price target shares abbott laboratories 77.00 81.00 gave stock overweight rating research report monday .
1416,they buy,cowen increased price target shares abbott laboratories 72.00 86.00 gave stock average rating research report friday .
1417,they buy,raymond james increased price target shares abbott laboratories 72.00 77.00 gave stock outperform rating research report monday september 24th .
1418,they buy,finally wells fargo co raised target price shares abbott laboratories 77.00 80.00 gave company outperform rating research report monday september 24th .
1419,they sell,one investment analyst rated stock sell rating four assigned hold rating fifteen assigned buy rating company stock .
1420,they buy,company average rating buy average price target 72.78 .
1421,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
1422,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1423,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed1 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1424,they sell,advanced emissions solutions ades lowered sell valuengine cypress capital group grew position shares abbott laboratories nyse abt 45.1 2nd quarter according company recent filing securities exchange commission .
1425,they buy,"institutional investor owned 108,355 shares healthcare product maker stock buying additional 33,665 shares quarter ."
1426,they buy,abbott laboratories accounts approximately 1.4 cypress capital group investment portfolio making stock 19th biggest holding .
1427,they buy,"cypress capital group holdings abbott laboratories worth 6,609,000 end recent quarter ."
1428,they sell,several institutional investors also recently bought sold shares abt .
1429,they buy,moody national bank trust division grew position shares abbott laboratories 7.3 2nd quarter .
1430,they buy,"moody national bank trust division owns 11,757 shares healthcare product maker stock valued 717,000 purchasing additional 795 shares last quarter ."
1431,they buy,sullivan bruyette speros blaney llc grew position shares abbott laboratories 4.2 2nd quarter .
1432,they buy,"sullivan bruyette speros blaney llc owns 19,760 shares healthcare product maker stock valued 1,205,000 purchasing additional 796 shares last quarter ."
1433,they buy,north star asset management inc. grew position shares abbott laboratories 0.3 2nd quarter .
1434,they buy,"north star asset management inc. owns 275,593 shares healthcare product maker stock valued 16,808,000 purchasing additional 828 shares last quarter ."
1435,they buy,lcnb corp grew position shares abbott laboratories 4.0 2nd quarter .
1436,they buy,"lcnb corp owns 21,412 shares healthcare product maker stock valued 1,306,000 purchasing additional 829 shares last quarter ."
1437,they buy,finally liberty mutual group asset management inc. lifted holdings shares abbott laboratories 1.2 2nd quarter .
1438,they buy,"liberty mutual group asset management inc. owns 70,078 shares healthcare product maker stock worth 4,274,000 acquiring additional 830 shares last quarter ."
1439,they buy,72.16 stock currently owned hedge funds institutional investors .
1440,they sell,related news insider sharon j. bracken sold 615 shares business stock transaction dated monday july 30th .
1441,they sell,"shares sold average price 65.16 total transaction 40,073.40 ."
1442,they buy,"following transaction insider owns 40,761 shares company valued 2,655,986.76 ."
1443,they buy,sale disclosed filing securities exchange commission available link .
1444,they sell,"also svp jaime contreras sold 64,268 shares business stock transaction dated wednesday august 29th ."
1445,they sell,"shares sold average price 66.84 total transaction 4,295,673.12 ."
1446,they buy,"following transaction senior vice president owns 125,471 shares company valued approximately 8,386,481.64 ."
1447,they buy,disclosure sale found .
1448,they sell,"insiders sold 155,321 shares company stock worth 10,492,583 last 90 days ."
1449,they buy,corporate insiders 0.74 company stock .
1450,they buy,abbott laboratories nyse abt last released quarterly earnings data wednesday july 18th .
1451,they buy,healthcare product maker reported 0.73 earnings per share eps quarter beating analysts consensus estimates 0.71 0.02 .
1452,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1453,they buy,firm revenue 7.77 billion quarter compared analysts expectations 7.71 billion .
1454,they sell,quarter previous year company earned 0.62 earnings per share .
1455,they buy,company revenue quarter 17.0 compared quarter last year .
1456,they buy,group equities analysts predict abbott laboratories post 2.88 eps current year .
1457,they buy,company also recently disclosed quarterly dividend paid thursday november 15th .
1458,they buy,shareholders record monday october 15th given 0.28 dividend .
1459,they buy,represents 1.12 dividend annualized basis dividend yield 1.57 .
1460,they buy,ex-dividend date friday october 12th .
1461,they buy,abbott laboratories payout ratio 44.80 .
1462,they buy,abt subject number research analyst reports .
1463,they buy,sanford c. bernstein initiated coverage shares abbott laboratories report wednesday june 27th .
1464,they buy,set outperform rating 73.00 price objective company .
1465,they buy,stifel nicolaus lifted price objective shares abbott laboratories 71.00 72.00 gave stock buy rating report thursday july 19th .
1466,they buy,zacks investment research raised shares abbott laboratories hold rating buy rating set 70.00 price objective company report thursday july 19th .
1467,they buy,royal bank canada reaffirmed buy rating set 70.00 price objective shares abbott laboratories report thursday july 19th .
1468,they buy,finally wells fargo co boosted price target shares abbott laboratories 77.00 80.00 gave stock outperform rating research note monday september 24th .
1469,they sell,one investment analyst rated stock sell rating four assigned hold rating fifteen assigned buy rating company .
1470,they buy,abbott laboratories average rating buy consensus price target 72.78 .
1471,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
1472,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1473,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1474,they buy,name required b.s .
1475,they buy,pension fund trustee ltd acting british steel pension fund lowered holdings abbott laboratories nyse abt 55.7 2nd quarter according company recent filing sec .
1476,they buy,"firm owned 3,411 shares healthcare product maker stock selling 4,289 shares quarter ."
1477,they buy,b.s .
1478,they buy,"pension fund trustee ltd acting british steel pension fund holdings abbott laboratories worth 208,000 end recent quarter ."
1479,they buy,number hedge funds institutional investors also added reduced stakes business .
1480,they buy,"rainier group investment advisory llc bought new position shares abbott laboratories 1st quarter worth approximately 114,000 ."
1481,they buy,"fny investment advisers llc bought new position shares abbott laboratories 2nd quarter worth approximately 118,000 ."
1482,they buy,"fort l.p. bought new position shares abbott laboratories 2nd quarter worth approximately 119,000 ."
1483,they buy,security national bank dak raised position shares abbott laboratories 72.0 2nd quarter .
1484,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 acquiring additional 878 shares last quarter ."
1485,they buy,"finally private ocean llc raised position shares abbott laboratories 9,868.2 1st quarter ."
1486,they buy,"private ocean llc owns 2,193 shares healthcare product maker stock worth 131,000 acquiring additional 2,171 shares last quarter ."
1487,they buy,institutional investors hedge funds 72.16 company stock .
1488,they buy,several research analysts recently issued reports abt shares .
1489,they buy,sanford c. bernstein started coverage abbott laboratories research report wednesday june 27th .
1490,they buy,issued outperform rating 73.00 target price company .
1491,they buy,stifel nicolaus increased target price abbott laboratories 71.00 72.00 gave stock buy rating research report thursday july 19th .
1492,they buy,zacks investment research raised abbott laboratories hold rating buy rating set 70.00 target price company research report thursday july 19th .
1493,they buy,royal bank canada reissued buy rating issued 70.00 target price shares abbott laboratories research report thursday july 19th .
1494,they buy,finally wells fargo co raised price objective abbott laboratories 77.00 80.00 gave company outperform rating research report monday september 24th .
1495,they sell,one research analyst rated stock sell rating four given hold rating fifteen given buy rating stock .
1496,they buy,company currently consensus rating buy average target price 72.78 .
1497,they sell,"abbott laboratories news insider daniel gesua sive salvadori sold 5,000 shares abbott laboratories stock transaction friday september 28th ."
1498,they sell,"stock sold average price 73.39 total value 366,950.00 ."
1499,they buy,"following completion sale insider owns 93,321 shares company stock valued approximately 6,848,828.19 ."
1500,they buy,transaction disclosed filing sec accessed sec website .
1501,they sell,"also svp sharon j. bracken sold 1,732 shares abbott laboratories stock transaction friday september 28th ."
1502,they sell,"stock sold average price 73.35 total value 127,042.20 ."
1503,they buy,"following completion sale senior vice president directly owns 39,229 shares company stock valued approximately 2,877,447.15 ."
1504,they buy,disclosure sale found .
1505,they sell,"last three months insiders sold 155,321 shares company stock valued 10,492,583 ."
1506,they buy,corporate insiders 0.74 company stock .
1507,they buy,abt stock traded 0.14 monday reaching 71.44 .
1508,they buy,"5,528,800 shares company traded hands compared average volume 5,946,999. abbott laboratories one year low 53.61 one year high 74.15 ."
1509,they buy,company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64. firm market cap 128.70 billion pe ratio 28.60 price-to-earnings-growth ratio 2.05 beta 1.49 .
1510,they buy,abbott laboratories nyse abt last posted quarterly earnings data wednesday july 18th .
1511,they buy,healthcare product maker reported 0.73 earnings per share quarter beating zacks consensus estimate 0.71 0.02 .
1512,they buy,company revenue 7.77 billion quarter compared analyst estimates 7.71 billion .
1513,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
1514,they buy,firm revenue quarter 17.0 year-over-year basis .
1515,they buy,quarter last year company earned 0.62 eps .
1516,they sell,average research analysts expect abbott laboratories post 2.88 earnings per share current fiscal year .
1517,they buy,firm also recently announced quarterly dividend paid thursday november 15th .
1518,they buy,shareholders record monday october 15th issued 0.28 dividend .
1519,they buy,represents 1.12 dividend annualized basis dividend yield 1.57 .
1520,they buy,ex-dividend date dividend friday october 12th .
1521,they buy,abbott laboratories payout ratio 44.80 .
1522,they buy,"abbott laboratories company profile keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1523,they buy,blackrock inc. increases position fti consulting inc. fcn price abbott laboratories nyse abt currently stands 71.58 went found strong support 70.93 share .
1524,they buy,abt price drops critical support would lead bearish trend .
1525,they buy,short-term dip 70.28 mark would also bad stock means stock would plunge 1.82 current position .
1526,they buy,however stock price able trade resistance point around 72.35 could likely surge higher try break upward resistance stands 73.11 share .
1527,they buy,average daily volatility past one month stands 1.22 .
1528,they buy,stock plunged 0.75 52-weeks high 71.045 reached oct. 01 2018. general 25.1 52-weeks lowest point stands 53.61 setback observed nov. 01 2017 .
1529,they buy,analysts predicted price target abbott laboratories abt 1 year stands average 72.71/share .
1530,they buy,means would likely increase 1.58 current position .
1531,they buy,current price stock moving 71.045 72.46 .
1532,they buy,brokerage firms lower target stock average one setting price target low 57 .
1533,they buy,hand one analyst super bullish price setting target high 86 .
1534,they buy,abt stock stochastic oscillator 62.57 means currently neutral .
1535,they buy,shares p/s ratio stands 4.26 compares 6.97 recorded industry 6.67 wider sector .
1536,they buy,stock currently estimated price-earnings p/e multiple 22.13 lower 54.77 multiple 12-month price-earnings p/e .
1537,they buy,company earnings gone quarterly increase rate 47.4 past five years .
1538,they buy,analysts view abbott laboratories nyse abt buy 1.8 consensus rating .
1539,they buy,reuters surveyed 18 analysts follow abt found 4 analysts rated stock hold .
1540,they sell,remaining 14 divided 14 analyst rating buy strong buy 0 analysts advised investors desist buying abbott laboratories abt shares sell already .
1541,they buy,posted lisa matthews oct 8th 2018 zurich insurance group ltd fi cut holdings shares abbott laboratories nyse abt 0.7 2nd quarter according recent form 13f filing securities exchange commission sec .
1542,they buy,"fund owned 292,089 shares healthcare product maker stock selling 1,980 shares period ."
1543,they buy,"zurich insurance group ltd fi holdings abbott laboratories worth 17,815,000 end recent reporting period ."
1544,they buy,several institutional investors also added reduced stakes stock .
1545,they buy,centaurus financial inc. raised stake shares abbott laboratories 113.0 second quarter .
1546,they buy,"centaurus financial inc. owns 10,742 shares healthcare product maker stock worth 655,000 buying additional 5,698 shares period ."
1547,they buy,security national bank dak boosted holdings shares abbott laboratories 72.0 2nd quarter .
1548,they buy,"security national bank dak owns 2,098 shares healthcare product maker stock worth 128,000 purchasing additional 878 shares period ."
1549,they buy,ae wealth management llc boosted holdings shares abbott laboratories 147.4 2nd quarter .
1550,they buy,"ae wealth management llc owns 16,423 shares healthcare product maker stock worth 1,002,000 purchasing additional 9,784 shares period ."
1551,they buy,tower research capital llc trc boosted holdings shares abbott laboratories 597.4 2nd quarter .
1552,they buy,"tower research capital llc trc owns 67,400 shares healthcare product maker stock worth 4,111,000 purchasing additional 57,736 shares period ."
1553,they buy,"finally sensato investors llc purchased new position shares abbott laboratories 2nd quarter worth approximately 226,000 ."
1554,they buy,72.16 stock currently owned institutional investors .
1555,they sell,news insider sharon j. bracken sold 615 shares company stock transaction dated monday july 30th .
1556,they sell,"stock sold average price 65.16 total value 40,073.40 ."
1557,they buy,"following sale insider owns 40,761 shares company valued 2,655,986.76 ."
1558,they buy,sale disclosed document filed securities exchange commission accessed link .
1559,they sell,"also evp brian j. blaser sold 15,100 shares company stock transaction dated tuesday july 24th ."
1560,they sell,"stock sold average price 63.96 total value 965,796.00 ."
1561,they buy,"following completion sale executive vice president owns 151,718 shares company valued approximately 9,703,883.28 ."
1562,they buy,disclosure sale found .
1563,they sell,"last quarter insiders sold 155,321 shares company stock worth 10,492,583 ."
1564,they buy,company insiders 0.74 company stock .
1565,they buy,shares abt stock opened 71.58 monday .
1566,they buy,abbott laboratories 1-year low 53.61 1-year high 74.15 .
1567,they buy,company current ratio 1.58 quick ratio 1.16 debt-to-equity ratio 0.64. firm market cap 128.70 billion p/e ratio 28.63 price-to-earnings-growth ratio 2.05 beta 1.49 .
1568,they buy,abbott laboratories nyse abt last announced earnings results wednesday july 18th .
1569,they buy,healthcare product maker reported 0.73 earnings per share quarter topping thomson reuters consensus estimate 0.71 0.02 .
1570,they buy,firm revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
1571,they buy,abbott laboratories return equity 15.30 net margin 3.13 .
1572,they buy,firm revenue quarter 17.0 year-over-year basis .
1573,they buy,period previous year business earned 0.62 eps .
1574,they sell,average equities research analysts forecast abbott laboratories post 2.88 earnings per share current fiscal year .
1575,they buy,company also recently declared quarterly dividend paid thursday november 15th .
1576,they buy,shareholders record monday october 15th paid dividend 0.28 per share .
1577,they buy,ex-dividend date friday october 12th .
1578,they buy,represents 1.12 annualized dividend yield 1.56 .
1579,they buy,abbott laboratories payout ratio presently 44.80 .
1580,they buy,abt subject number recent research reports .
1581,they buy,sanford c. bernstein started coverage abbott laboratories report wednesday june 27th .
1582,they buy,issued outperform rating 73.00 target price company .
1583,they buy,stifel nicolaus raised price target abbott laboratories 71.00 72.00 gave stock buy rating research note thursday july 19th .
1584,they buy,zacks investment research raised abbott laboratories hold rating buy rating set 70.00 target price company research report thursday july 19th .
1585,they buy,royal bank canada reaffirmed buy rating set 70.00 target price shares abbott laboratories research report thursday july 19th .
1586,they buy,finally wells fargo co lifted target price abbott laboratories 77.00 80.00 gave company outperform rating research report monday september 24th .
1587,they buy,five investment analysts rated stock hold rating fifteen issued buy rating company .
1588,they buy,abbott laboratories presently average rating buy average price target 72.11 .
1589,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
1590,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1591,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 sec filings,13f hedge fund holdings institutional investor holdingsratings:4,18 nyse abtrefreshed3 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1592,they sell,"berenberg bank analysts give cme group nasdaq cme 184.00 price target abbott laboratories nyse abt insider brian j. blaser sold 58,200 shares business stock transaction occurred thursday september 20th ."
1593,they sell,"shares sold average price 68.79 total value 4,003,578.00 ."
1594,they buy,"following completion sale insider owns 184,918 shares company stock valued approximately 12,720,509.22 ."
1595,they buy,sale disclosed legal filing securities exchange commission accessible sec website .
1596,they buy,shares nyse abt opened 71.58 monday .
1597,they buy,company market capitalization 128.70 billion p/e ratio 28.63 price-to-earnings-growth ratio 2.05 beta 1.49. abbott laboratories 52 week low 53.61 52 week high 74.15 .
1598,they buy,company quick ratio 1.16 current ratio 1.58 debt-to-equity ratio 0.64 .
1599,they buy,abbott laboratories nyse abt last issued quarterly earnings data wednesday july 18th .
1600,they buy,healthcare product maker reported 0.73 eps quarter topping analysts consensus estimates 0.71 0.02 .
1601,they buy,company revenue 7.77 billion quarter compared consensus estimate 7.71 billion .
1602,they buy,abbott laboratories net margin 3.13 return equity 15.30 .
1603,they buy,abbott laboratories revenue quarter 17.0 compared quarter last year .
1604,they sell,quarter previous year firm posted 0.62 earnings per share .
1605,they sell,average sell-side analysts predict abbott laboratories post 2.88 eps current fiscal year .
1606,they buy,firm also recently declared quarterly dividend paid thursday november 15th .
1607,they buy,stockholders record monday october 15th given dividend 0.28 per share .
1608,they buy,represents 1.12 dividend annualized basis dividend yield 1.56 .
1609,they buy,ex-dividend date friday october 12th .
1610,they buy,abbott laboratories payout ratio presently 44.80 .
1611,they buy,number brokerages recently issued reports abt .
1612,they buy,royal bank canada reiterated buy rating issued 70.00 price target shares abbott laboratories report thursday july 19th .
1613,they buy,stifel nicolaus boosted price target abbott laboratories 71.00 72.00 gave company buy rating report thursday july 19th .
1614,they buy,zacks investment research lowered abbott laboratories buy rating hold rating report monday august 6th .
1615,they buy,sanford c. bernstein began coverage abbott laboratories report wednesday june 27th .
1616,they buy,issued outperform rating 73.00 price target company .
1617,they buy,finally raymond james boosted price objective shares abbott laboratories 72.00 77.00 gave stock outperform rating research note monday september 24th .
1618,they buy,five research analysts rated stock hold rating fifteen assigned buy rating stock .
1619,they buy,company average rating buy consensus target price 72.11 .
1620,they buy,several hedge funds recently modified holdings abt .
1621,they buy,cambridge investment research advisors inc. increased position shares abbott laboratories 1.7 first quarter .
1622,they buy,"cambridge investment research advisors inc. owns 202,155 shares healthcare product maker stock worth 12,113,000 purchasing additional 3,327 shares last quarter ."
1623,they buy,"silvant capital management llc acquired new position shares abbott laboratories first quarter worth 160,000 ."
1624,they buy,"ceredex value advisors llc acquired new position shares abbott laboratories first quarter worth 97,236,000 ."
1625,they buy,"rockefeller capital management l.p. acquired new position shares abbott laboratories first quarter worth 17,312,000 ."
1626,they buy,finally pegasus partners ltd. increased position shares abbott laboratories 14.7 first quarter .
1627,they buy,"pegasus partners ltd. owns 45,060 shares healthcare product maker stock worth 2,700,000 purchasing additional 5,790 shares last quarter ."
1628,they buy,72.16 stock currently owned institutional investors hedge funds .
1629,they buy,abbott laboratories company profile abbott laboratories discovers develops manufactures sells health care products worldwide .
1630,they buy,company established pharmaceutical products segment offers branded generic pharmaceuticals treatment pancreatic exocrine insufficiency irritable bowel syndrome biliary spasm intrahepatic cholestasis depressive symptoms gynecological disorders hormone replacement therapy dyslipidemia hypertension hypothyroidism ménière disease vestibular vertigo pain fever inflammation migraines anti-infective clarithromycin well provides influenza vaccine products regulate physiological rhythm colon .
1631,they buy,"keyword abbott laboratories nyse abt abt medical,00282410 insider trading insider trades stocksratings:4,18 nyse abtrefreshed2 receive news ratings abbott laboratories daily enter email address receive concise daily summary latest news analysts ratings abbott laboratories related companies marketbeat.com free daily email newsletter ."
1632,they buy,0.18 eps expected oncosec medical inc oncs quarter
